var title_f41_5_42064="Dreiling tube";
var content_f41_5_42064=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F72009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F72009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dreiling tube",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 383px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fluoroscopic image showing proper placement of the double-lumen gastroduodenal (Dreiling) collection tube for performance of direct pancreatic function testing. The proximal lumen is situated in the gastric antrum to collect and discard gastric secretion. The distal lumen is deep within the duodenum with the tip of the tube at the ligament of Treitz for continuous collection of duodenal fluid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cleveland Clinic Foundation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42064=[""].join("\n");
var outline_f41_5_42064=null;
var title_f41_5_42065="Shoulder external rotation isometric exercise";
var content_f41_5_42065=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1094px;\">",
"  <div class=\"videoplayer\" h264=\"./images/EM/86059/Sh_ext_rotat_isometr_video.mp4?title=Shoulder+external+rotation+isometric+exercise\" style=\"width:448px;height:288px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Shoulder external rotation isometric exercise",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Isometric holds performed with the shoulder externally rotated are used&nbsp;early during rehabilitation&nbsp;to strengthen the muscles that perform external rotation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Craig Parsons, MS, PT and the Physical Therapy Network.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42065=[""].join("\n");
var outline_f41_5_42065=null;
var title_f41_5_42066="Patient information: Allergy shots (The Basics)";
var content_f41_5_42066=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/86635\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/41/7824\">",
"         Hives",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/55/32626\">",
"          Angioedema of the lips and tongue",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?32/30/33250\">",
"         Patient information: Anaphylaxis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?28/57/29586\">",
"         Patient information: Epinephrine auto-injectors (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?24/42/25250\">",
"         Patient information: Insect allergy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/38/37474\">",
"         Patient information: Seasonal allergies in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?13/10/13475\">",
"         Patient information: Seasonal allergies in children (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?5/27/5553\">",
"         Patient information: Allergic conjunctivitis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?40/8/41092\">",
"         Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?5/40/5764\">",
"         Patient information: Trigger avoidance in allergic rhinitis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/30/28134\">",
"         Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Allergy shots (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H552534981\">",
"      <span class=\"h1\">",
"       What are allergy shots?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Allergy shots are injections (shots) that can make you less likely to have allergy symptoms. The shots are usually made to order, just for you. They contain tiny amounts of the things that you are allergic to, such as pollen or mold. If you are allergic to stings from bees or other insects, allergy shots can lower your chances of having a dangerous reaction to a sting in the future.",
"     </p>",
"     <p>",
"      Allergy shots work for allergies to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pollen from trees, weeds, and grasses",
"       </li>",
"       <li>",
"        Mold spores in the outside air",
"       </li>",
"       <li>",
"        Tiny flakes (called &ldquo;dander&rdquo;) from the fur, hair, or skin of a cat or dog",
"       </li>",
"       <li>",
"        Tiny insects found in dust, called &ldquo;dust mites&rdquo;",
"       </li>",
"       <li>",
"        Stings from honeybees, yellow jackets, hornets, wasps, and (in some areas) fire ants",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Allergy shots are NOT used to treat allergies to food, latex, or medicines.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H552534996\">",
"      <span class=\"h1\">",
"       Why do I need allergy shots?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have allergies, you should avoid pollen, molds, and other things that cause your allergies. You can also take allergy medicines. But if those treatments don&rsquo;t work well enough, your doctor might recommend allergy shots.",
"     </p>",
"     <p>",
"      He or she will also recommend allergy shots if you had a serious allergic reaction to a sting from a bee or other insect. Symptoms of a serious allergic reaction include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Flushing &ndash; Flushing is when your skin turns red and feels hot, especially on your face.",
"       </li>",
"       <li>",
"        Hives &ndash; These are red, raised patches of skin that are very itchy (",
"        <a class=\"graphic graphic_picture graphicRef79242 \" href=\"mobipreview.htm?7/41/7824\">",
"         picture 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Angioedema &ndash; This is swelling of the face, eyelids, mouth, tongue, hands, and feet (",
"        <a class=\"graphic graphic_picture graphicRef73131 \" href=\"mobipreview.htm?31/55/32626\">",
"         picture 2",
"        </a>",
"        ).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you get an insect sting in the future, you might have a dangerous reaction called &ldquo;anaphylaxis.&rdquo; If you have anaphylaxis, you might:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have trouble breathing, become hoarse, or start wheezing (hearing a whistling sound when you breathe)",
"       </li>",
"       <li>",
"        Start to swell, especially in the throat or around the face, eyelids, mouth, hands, or feet",
"       </li>",
"       <li>",
"        Develop belly cramps, nausea, vomiting, or diarrhea",
"       </li>",
"       <li>",
"        Feel dizzy or pass out",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Allergy shots for insect stings will make you much less likely to get anaphylaxis.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H552535059\">",
"      <span class=\"h1\">",
"       Are allergy shots safe for everyone?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Allergy shots can be safe for people of all ages. If a woman gets pregnant while she is getting allergy shots, she can keep getting the shots. But pregnant women should wait until after giving birth to start allergy shots for the first time.",
"     </p>",
"     <p>",
"      Some medicines, such as beta blockers, can cause problems in people getting allergy shots. Make sure your doctor knows all the medicines you take before starting allergy shots. In some cases, you might need to change your medicines in order to get allergy shots.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H552535074\">",
"      <span class=\"h1\">",
"       What happens when I get an allergy shot?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people take an antihistamine before each visit for allergy shots. Your doctor might tell you not to exercise 1 to 2 hours before and after your allergy shot.",
"     </p>",
"     <p>",
"      When you get to the office, the nurse or doctor might ask you for your name and birth date to make sure you get the right injection and not 1 made for someone else. You might get just 1 or several shots, depending on how many things you are allergic to. After getting the shot, you will need to stay in the office or clinic for 30 minutes to make sure you do not have a serious reaction to the shot.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H552535089\">",
"      <span class=\"h1\">",
"       What type of reactions can happen after an allergy shots?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are 2 types of reactions to allergy shots. The area where the shot was given might turn red, swell, and itch. This is called a local reaction. It can be uncomfortable, but it isn&rsquo;t dangerous.",
"     </p>",
"     <p>",
"      In rare cases, people get anaphylaxis from an allergy shot. If that happens, it can be treated with a shot of a medicine called epinephrine.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H552535104\">",
"      <span class=\"h1\">",
"       How often and how long will I need to get allergy shots?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most people get allergy shots for 3 to 5 years, although some get them for longer. The first few months, the shots are given 1 to 3 times a week. During this time, the shots get gradually stronger, and allergy symptoms start to improve. After the shots have reached full strength, they are usually given once every 2 to 4 weeks. Symptoms then keep improving over the first few years.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H552535121\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/38/37474?source=see_link\">",
"       Patient information: Seasonal allergies in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/42/25250?source=see_link\">",
"       Patient information: Insect allergy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/30/33250?source=see_link\">",
"       Patient information: Anaphylaxis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?28/57/29586?source=see_link\">",
"       Patient information: Epinephrine auto-injectors (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/10/13475?source=see_link\">",
"       Patient information: Seasonal allergies in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/8/41092?source=see_link\">",
"       Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/40/5764?source=see_link\">",
"       Patient information: Trigger avoidance in allergic rhinitis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/27/5553?source=see_link\">",
"       Patient information: Allergic conjunctivitis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/30/28134?source=see_link\">",
"       Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?41/5/42066?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86635 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-168C04E0CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42066=[""].join("\n");
var outline_f41_5_42066=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H552534981\">",
"      What are allergy shots?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H552534996\">",
"      Why do I need allergy shots?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H552535059\">",
"      Are allergy shots safe for everyone?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H552535074\">",
"      What happens when I get an allergy shot?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H552535089\">",
"      What type of reactions can happen after an allergy shots?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H552535104\">",
"      How often and how long will I need to get allergy shots?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H552535121\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/86635\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/41/7824\">",
"      Hives",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/55/32626\">",
"       Angioedema of the lips and tongue",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/27/5553?source=related_link\">",
"      Patient information: Allergic conjunctivitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/8/41092?source=related_link\">",
"      Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/30/33250?source=related_link\">",
"      Patient information: Anaphylaxis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?28/57/29586?source=related_link\">",
"      Patient information: Epinephrine auto-injectors (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/42/25250?source=related_link\">",
"      Patient information: Insect allergy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/38/37474?source=related_link\">",
"      Patient information: Seasonal allergies in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/10/13475?source=related_link\">",
"      Patient information: Seasonal allergies in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/40/5764?source=related_link\">",
"      Patient information: Trigger avoidance in allergic rhinitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/30/28134?source=related_link\">",
"      Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_5_42067="Calculator: Estimated Date of Delivery (EDD)";
var content_f41_5_42067=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"EstimatedDateDelivery_form\" name=\"EstimatedDateDelivery_form\" onkeydown=\"clrResults();\" onkeypress=\"return validNumberField(event);\" onkeyup=\"EstimatedDateDelivery_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Estimated Date of Delivery (EDD)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Current Date",
"             </span>",
"            </td>",
"            <td align=\"left\" colspan=\"2\" nowrap=\"nowrap\">",
"             &nbsp;&nbsp;",
"             <select class=\"medCalcFontSelect\" name=\"current_month\" onchange=\"EstimatedDateDelivery_fx();\">",
"              <option value=\"0\">",
"               Jan",
"              </option>",
"              <option value=\"1\">",
"               Feb",
"              </option>",
"              <option value=\"2\">",
"               Mar",
"              </option>",
"              <option value=\"3\">",
"               Apr",
"              </option>",
"              <option value=\"4\">",
"               May",
"              </option>",
"              <option value=\"5\">",
"               Jun",
"              </option>",
"              <option value=\"6\">",
"               Jul",
"              </option>",
"              <option value=\"7\">",
"               Aug",
"              </option>",
"              <option value=\"8\">",
"               Sep",
"              </option>",
"              <option value=\"9\">",
"               Oct",
"              </option>",
"              <option value=\"10\">",
"               Nov",
"              </option>",
"              <option value=\"11\">",
"               Dec",
"              </option>",
"              <option selected=\"selected\" value=\"-1\">",
"               MM",
"              </option>",
"             </select>",
"             <select class=\"medCalcFontSelect\" name=\"current_date\" onchange=\"EstimatedDateDelivery_fx();\">",
"              <option value=\"1\">",
"               1",
"              </option>",
"              <option value=\"2\">",
"               2",
"              </option>",
"              <option value=\"3\">",
"               3",
"              </option>",
"              <option value=\"4\">",
"               4",
"              </option>",
"              <option value=\"5\">",
"               5",
"              </option>",
"              <option value=\"6\">",
"               6",
"              </option>",
"              <option value=\"7\">",
"               7",
"              </option>",
"              <option value=\"8\">",
"               8",
"              </option>",
"              <option value=\"9\">",
"               9",
"              </option>",
"              <option value=\"10\">",
"               10",
"              </option>",
"              <option value=\"11\">",
"               11",
"              </option>",
"              <option value=\"12\">",
"               12",
"              </option>",
"              <option value=\"13\">",
"               13",
"              </option>",
"              <option value=\"14\">",
"               14",
"              </option>",
"              <option value=\"15\">",
"               15",
"              </option>",
"              <option value=\"16\">",
"               16",
"              </option>",
"              <option value=\"17\">",
"               17",
"              </option>",
"              <option value=\"18\">",
"               18",
"              </option>",
"              <option value=\"19\">",
"               19",
"              </option>",
"              <option value=\"20\">",
"               20",
"              </option>",
"              <option value=\"21\">",
"               21",
"              </option>",
"              <option value=\"22\">",
"               22",
"              </option>",
"              <option value=\"23\">",
"               23",
"              </option>",
"              <option value=\"24\">",
"               24",
"              </option>",
"              <option value=\"25\">",
"               25",
"              </option>",
"              <option value=\"26\">",
"               26",
"              </option>",
"              <option value=\"27\">",
"               27",
"              </option>",
"              <option value=\"28\">",
"               28",
"              </option>",
"              <option value=\"29\">",
"               29",
"              </option>",
"              <option value=\"30\">",
"               30",
"              </option>",
"              <option value=\"31\">",
"               31",
"              </option>",
"              <option selected=\"selected\" value=\"-1\">",
"               DD",
"              </option>",
"             </select>",
"             <select class=\"medCalcFontSelect\" name=\"current_year\" onchange=\"EstimatedDateDelivery_fx();\">",
"              <option value=\"2009\">",
"               2009",
"              </option>",
"              <option value=\"2010\">",
"               2010",
"              </option>",
"              <option value=\"2011\">",
"               2011",
"              </option>",
"              <option value=\"2012\">",
"               2012",
"              </option>",
"              <option value=\"2013\">",
"               2013",
"              </option>",
"              <option value=\"2014\">",
"               2014",
"              </option>",
"              <option value=\"2015\">",
"               2015",
"              </option>",
"              <option value=\"2016\">",
"               2016",
"              </option>",
"              <option value=\"2017\">",
"               2017",
"              </option>",
"              <option value=\"2018\">",
"               2018",
"              </option>",
"              <option value=\"2019\">",
"               2019",
"              </option>",
"              <option value=\"2020\">",
"               2020",
"              </option>",
"              <option value=\"2021\">",
"               2021",
"              </option>",
"              <option value=\"2022\">",
"               2022",
"              </option>",
"              <option value=\"2023\">",
"               2023",
"              </option>",
"              <option value=\"2024\">",
"               2024",
"              </option>",
"              <option value=\"2025\">",
"               2025",
"              </option>",
"              <option value=\"2026\">",
"               2026",
"              </option>",
"              <option value=\"2027\">",
"               2027",
"              </option>",
"              <option value=\"2028\">",
"               2028",
"              </option>",
"              <option value=\"2029\">",
"               2029",
"              </option>",
"              <option value=\"2030\">",
"               2030",
"              </option>",
"              <option selected=\"selected\" value=\"-1\">",
"               YYYY",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Last Menstrual Period",
"             </span>",
"            </td>",
"            <td align=\"left\" colspan=\"2\" nowrap=\"nowrap\">",
"             &nbsp;&nbsp;",
"             <select class=\"medCalcFontSelect\" name=\"lmp_month\" onchange=\"EstimatedDateDelivery_fx();\">",
"              <option value=\"0\">",
"               Jan",
"              </option>",
"              <option value=\"1\">",
"               Feb",
"              </option>",
"              <option value=\"2\">",
"               Mar",
"              </option>",
"              <option value=\"3\">",
"               Apr",
"              </option>",
"              <option value=\"4\">",
"               May",
"              </option>",
"              <option value=\"5\">",
"               Jun",
"              </option>",
"              <option value=\"6\">",
"               Jul",
"              </option>",
"              <option value=\"7\">",
"               Aug",
"              </option>",
"              <option value=\"8\">",
"               Sep",
"              </option>",
"              <option value=\"9\">",
"               Oct",
"              </option>",
"              <option value=\"10\">",
"               Nov",
"              </option>",
"              <option value=\"11\">",
"               Dec",
"              </option>",
"              <option selected=\"selected\" value=\"-1\">",
"               MM",
"              </option>",
"             </select>",
"             <select class=\"medCalcFontSelect\" name=\"lmp_date\" onchange=\"EstimatedDateDelivery_fx();\">",
"              <option value=\"1\">",
"               1",
"              </option>",
"              <option value=\"2\">",
"               2",
"              </option>",
"              <option value=\"3\">",
"               3",
"              </option>",
"              <option value=\"4\">",
"               4",
"              </option>",
"              <option value=\"5\">",
"               5",
"              </option>",
"              <option value=\"6\">",
"               6",
"              </option>",
"              <option value=\"7\">",
"               7",
"              </option>",
"              <option value=\"8\">",
"               8",
"              </option>",
"              <option value=\"9\">",
"               9",
"              </option>",
"              <option value=\"10\">",
"               10",
"              </option>",
"              <option value=\"11\">",
"               11",
"              </option>",
"              <option value=\"12\">",
"               12",
"              </option>",
"              <option value=\"13\">",
"               13",
"              </option>",
"              <option value=\"14\">",
"               14",
"              </option>",
"              <option value=\"15\">",
"               15",
"              </option>",
"              <option value=\"16\">",
"               16",
"              </option>",
"              <option value=\"17\">",
"               17",
"              </option>",
"              <option value=\"18\">",
"               18",
"              </option>",
"              <option value=\"19\">",
"               19",
"              </option>",
"              <option value=\"20\">",
"               20",
"              </option>",
"              <option value=\"21\">",
"               21",
"              </option>",
"              <option value=\"22\">",
"               22",
"              </option>",
"              <option value=\"23\">",
"               23",
"              </option>",
"              <option value=\"24\">",
"               24",
"              </option>",
"              <option value=\"25\">",
"               25",
"              </option>",
"              <option value=\"26\">",
"               26",
"              </option>",
"              <option value=\"27\">",
"               27",
"              </option>",
"              <option value=\"28\">",
"               28",
"              </option>",
"              <option value=\"29\">",
"               29",
"              </option>",
"              <option value=\"30\">",
"               30",
"              </option>",
"              <option value=\"31\">",
"               31",
"              </option>",
"              <option selected=\"selected\" value=\"-1\">",
"               DD",
"              </option>",
"             </select>",
"             <select class=\"medCalcFontSelect\" name=\"lmp_year\" onchange=\"EstimatedDateDelivery_fx();\">",
"              <option value=\"2009\">",
"               2009",
"              </option>",
"              <option value=\"2010\">",
"               2010",
"              </option>",
"              <option value=\"2011\">",
"               2011",
"              </option>",
"              <option value=\"2012\">",
"               2012",
"              </option>",
"              <option value=\"2013\">",
"               2013",
"              </option>",
"              <option value=\"2014\">",
"               2014",
"              </option>",
"              <option value=\"2015\">",
"               2015",
"              </option>",
"              <option value=\"2016\">",
"               2016",
"              </option>",
"              <option value=\"2017\">",
"               2017",
"              </option>",
"              <option value=\"2018\">",
"               2018",
"              </option>",
"              <option value=\"2019\">",
"               2019",
"              </option>",
"              <option value=\"2020\">",
"               2020",
"              </option>",
"              <option value=\"2021\">",
"               2021",
"              </option>",
"              <option value=\"2022\">",
"               2022",
"              </option>",
"              <option value=\"2023\">",
"               2023",
"              </option>",
"              <option value=\"2024\">",
"               2024",
"              </option>",
"              <option value=\"2025\">",
"               2025",
"              </option>",
"              <option value=\"2026\">",
"               2026",
"              </option>",
"              <option value=\"2027\">",
"               2027",
"              </option>",
"              <option value=\"2028\">",
"               2028",
"              </option>",
"              <option value=\"2029\">",
"               2029",
"              </option>",
"              <option value=\"2030\">",
"               2030",
"              </option>",
"              <option selected=\"selected\" value=\"-1\">",
"               YYYY",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Ultrasound Date",
"             </span>",
"            </td>",
"            <td align=\"left\" colspan=\"2\" nowrap=\"nowrap\">",
"             &nbsp;&nbsp;",
"             <select class=\"medCalcFontSelect\" name=\"us_month\" onchange=\"EstimatedDateDelivery_fx();\">",
"              <option value=\"0\">",
"               Jan",
"              </option>",
"              <option value=\"1\">",
"               Feb",
"              </option>",
"              <option value=\"2\">",
"               Mar",
"              </option>",
"              <option value=\"3\">",
"               Apr",
"              </option>",
"              <option value=\"4\">",
"               May",
"              </option>",
"              <option value=\"5\">",
"               Jun",
"              </option>",
"              <option value=\"6\">",
"               Jul",
"              </option>",
"              <option value=\"7\">",
"               Aug",
"              </option>",
"              <option value=\"8\">",
"               Sep",
"              </option>",
"              <option value=\"9\">",
"               Oct",
"              </option>",
"              <option value=\"10\">",
"               Nov",
"              </option>",
"              <option value=\"11\">",
"               Dec",
"              </option>",
"              <option selected=\"selected\" value=\"-1\">",
"               MM",
"              </option>",
"             </select>",
"             <select class=\"medCalcFontSelect\" name=\"us_date\" onchange=\"EstimatedDateDelivery_fx();\">",
"              <option value=\"1\">",
"               1",
"              </option>",
"              <option value=\"2\">",
"               2",
"              </option>",
"              <option value=\"3\">",
"               3",
"              </option>",
"              <option value=\"4\">",
"               4",
"              </option>",
"              <option value=\"5\">",
"               5",
"              </option>",
"              <option value=\"6\">",
"               6",
"              </option>",
"              <option value=\"7\">",
"               7",
"              </option>",
"              <option value=\"8\">",
"               8",
"              </option>",
"              <option value=\"9\">",
"               9",
"              </option>",
"              <option value=\"10\">",
"               10",
"              </option>",
"              <option value=\"11\">",
"               11",
"              </option>",
"              <option value=\"12\">",
"               12",
"              </option>",
"              <option value=\"13\">",
"               13",
"              </option>",
"              <option value=\"14\">",
"               14",
"              </option>",
"              <option value=\"15\">",
"               15",
"              </option>",
"              <option value=\"16\">",
"               16",
"              </option>",
"              <option value=\"17\">",
"               17",
"              </option>",
"              <option value=\"18\">",
"               18",
"              </option>",
"              <option value=\"19\">",
"               19",
"              </option>",
"              <option value=\"20\">",
"               20",
"              </option>",
"              <option value=\"21\">",
"               21",
"              </option>",
"              <option value=\"22\">",
"               22",
"              </option>",
"              <option value=\"23\">",
"               23",
"              </option>",
"              <option value=\"24\">",
"               24",
"              </option>",
"              <option value=\"25\">",
"               25",
"              </option>",
"              <option value=\"26\">",
"               26",
"              </option>",
"              <option value=\"27\">",
"               27",
"              </option>",
"              <option value=\"28\">",
"               28",
"              </option>",
"              <option value=\"29\">",
"               29",
"              </option>",
"              <option value=\"30\">",
"               30",
"              </option>",
"              <option value=\"31\">",
"               31",
"              </option>",
"              <option selected=\"selected\" value=\"-1\">",
"               DD",
"              </option>",
"             </select>",
"             <select class=\"medCalcFontSelect\" name=\"us_year\" onchange=\"EstimatedDateDelivery_fx();\">",
"              <option value=\"2009\">",
"               2009",
"              </option>",
"              <option value=\"2010\">",
"               2010",
"              </option>",
"              <option value=\"2011\">",
"               2011",
"              </option>",
"              <option value=\"2012\">",
"               2012",
"              </option>",
"              <option value=\"2013\">",
"               2013",
"              </option>",
"              <option value=\"2014\">",
"               2014",
"              </option>",
"              <option value=\"2015\">",
"               2015",
"              </option>",
"              <option value=\"2016\">",
"               2016",
"              </option>",
"              <option value=\"2017\">",
"               2017",
"              </option>",
"              <option value=\"2018\">",
"               2018",
"              </option>",
"              <option value=\"2019\">",
"               2019",
"              </option>",
"              <option value=\"2020\">",
"               2020",
"              </option>",
"              <option value=\"2021\">",
"               2021",
"              </option>",
"              <option value=\"2022\">",
"               2022",
"              </option>",
"              <option value=\"2023\">",
"               2023",
"              </option>",
"              <option value=\"2024\">",
"               2024",
"              </option>",
"              <option value=\"2025\">",
"               2025",
"              </option>",
"              <option value=\"2026\">",
"               2026",
"              </option>",
"              <option value=\"2027\">",
"               2027",
"              </option>",
"              <option value=\"2028\">",
"               2028",
"              </option>",
"              <option value=\"2029\">",
"               2029",
"              </option>",
"              <option value=\"2030\">",
"               2030",
"              </option>",
"              <option selected=\"selected\" value=\"-1\">",
"               YYYY",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Gestational Age by US",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Gestational_Age_by_US_param\" onblur=\"EstimatedDateDelivery_fx(); minMaxCheck();\" onchange=\"EstimatedDateDelivery_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"108\">",
"             <select class=\"medCalcFontSelect\" name=\"Gestational_Age_by_US_unit\" onchange=\"EstimatedDateDelivery_fx();\" style=\"width:98px;\">",
"              <option value=\"0.142857142857143|0|days\">",
"               days",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|weeks\">",
"               weeks",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Results:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Current Gestational Age by LMP",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input maxlength=\"16\" name=\"current_gest_lmp\" onfocus=\"blur();\" size=\"16\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              EDD by LMP",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input maxlength=\"16\" name=\"edd_lmp_result\" onfocus=\"blur();\" size=\"16\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Current Gestational Age by US",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input maxlength=\"16\" name=\"current_gest_us\" onfocus=\"blur();\" size=\"16\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              EDD by US",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input maxlength=\"16\" name=\"edd_us_result\" onfocus=\"blur();\" size=\"16\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"     </span>",
"    </div>",
"    <div id=\"calc_notes\">",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       This calculator gives you two options for estimating",
"       <b>",
"        EDD",
"       </b>",
"       (estimated date of delivery.)",
"      </li>",
"      <li>",
"       Input any parameters to compare the two date calculations.",
"      </li>",
"      <li>",
"       <b>",
"        Gestational Age by LMP",
"       </b>",
"       is calculated from the first day of the last menstrual period.",
"      </li>",
"      <li>",
"       <b>",
"        EDD by LMP",
"       </b>",
"       is calculated by adding 280 days (40 weeks) to the first day of the last menstrual period.",
"      </li>",
"      <li>",
"       <b>",
"        Gestational Age by US",
"       </b>",
"       is measured by ultrasound (US) on the",
"       <b>",
"        Ultrasound Date",
"       </b>",
"       .",
"      </li>",
"      <li>",
"       <b>",
"        EDD by US",
"       </b>",
"       is the estimated date of delivery based on the",
"       <b>",
"        Gestational Age by US",
"       </b>",
"       and the",
"       <b>",
"        Ultrasound Date",
"       </b>",
"       .",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Mul T, Mongelli M, Gardosi J. A comparative analysis of second-trimester ultrasound dating formulae in pregnancies conceived with artificial reproductive techniques.",
"        <i>",
"         Ultrasound Obstet Gynecol",
"        </i>",
"        . 1996 Dec;8(6):397-402.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Westerway SC, Davison A, Cowell S. Ultrasonic fetal measurements: new Australian standards for the new millennium.",
"        <i>",
"         Aust N Z J Obstet Gynaecol",
"        </i>",
"        . 2000 Aug;40(3):297-302.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Altman DG, Chitty LS. New charts for ultrasound dating of pregnancy.",
"        <i>",
"         Ultrasound Obstet Gynecol",
"        </i>",
"        . 1997 Sep;10(3):174-91.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"   <script language=\"JavaScript1.1\" type=\"text/javascript\">",
"    &lt;!--",
"",
"with(document.EstimatedDateDelivery_form){",
"todaydatetime = new Date;",
"todaymonth = todaydatetime.getMonth();",
"todaydate = todaydatetime.getDate();",
"todayfullyear = todaydatetime.getFullYear();",
"",
"}",
"//--&gt;",
"   </script>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42067=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"function alertNaN(){",
"alert('This field is improperly formatted. You may only input the digits 0-9 and a decimal point.');  ",
"doCalc = false; ",
"clrResults();",
"}",
"",
"",
"function validNumberField(event) {",
"var field = event.target;",
"",
"if(field && field != 'undefined' && field.attributes.type.nodeValue && (field.attributes.type.nodeValue == 'number')) {",
"var val = field.value;",
"var charCode = event.charCode;",
"var key = String.fromCharCode(charCode);",
"",
"if(charCode == 0) {",
"return true;",
"}",
"",
"if(key == ' ') {",
"alert('Numeric field cannot contain spaces.');",
"return false;",
"}	",
"		",
"if(val.length == 0) {",
"if(key == '+') { return true; }",
"if(key == '-') { return true; }	",
"if(key == '.') { return true; }",
"}",
"		",
"if(key == '.') { return validFloat(val, key); }",
"",
"if(isNaN(parseInt(key))) {",
"alertNaN();",
"return false;",
"}",
"	",
"return validFloat(val, key);",
"}",
"return true;",
"}",
"",
"",
"function validFloat(val, key) {",
"var currentVal = parseFloat(val + key);",
"if(isNaN(val + key) || isNaN(currentVal)) {",
"alertNaN();",
"}",
"return true;",
"}",
"",
"var currenttimeout;",
"",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function EstimatedDateDelivery_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 2000);",
"",
"with(document.EstimatedDateDelivery_form){",
"",
"",
"doCalc = true;",
"param_value = parseFloat(Gestational_Age_by_US_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Gestational_Age_by_US_unit.options[Gestational_Age_by_US_unit.selectedIndex].value.split('|');",
"Gestational_Age_by_US = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = 0;",
"monthname = new Array('Jan', 'Feb', 'Mar', 'Apr', 'May', 'Jun', 'Jul', 'Aug', 'Sep', 'Oct', 'Nov', 'Dec');",
"current_time = new Date;",
"lmp_time = new Date;",
"us_time = new Date;",
"edd_lmp = new Date;",
"edd_us = new Date;",
"var current_month_value = parseFloat(current_month.options[current_month.selectedIndex].value);",
"var current_date_value = parseFloat(current_date.options[current_date.selectedIndex].value);",
"var current_year_value = parseFloat(current_year.options[current_year.selectedIndex].value);",
"if ((current_month_value == 1) && (current_date_value > 28)){",
"if ((current_year_value % 4) == 0){ current_date_value = 29; current_date.selectedIndex = 28; }",
"else{ current_date_value = 28; current_date.selectedIndex = 27; };",
"}",
"if (((current_month_value == 3) || (current_month_value == 5) || (current_month_value == 8) || (current_month_value == 10)) && (current_date_value > 30)){ current_date_value = 30; current_date.selectedIndex = 29; };",
"current_time.setFullYear(current_year_value);",
"current_time.setMonth(current_month_value, current_date_value);",
"current_time.setHours(0);",
"var lmp_month_value = parseFloat(lmp_month.options[lmp_month.selectedIndex].value);",
"var lmp_date_value = parseFloat(lmp_date.options[lmp_date.selectedIndex].value);",
"var lmp_year_value = parseFloat(lmp_year.options[lmp_year.selectedIndex].value);",
"if ((lmp_month_value == 1) && (lmp_date_value > 28)){",
"if ((lmp_year_value % 4) == 0){ lmp_date_value = 29; lmp_date.selectedIndex = 28; }",
"else{ lmp_date_value = 28; lmp_date.selectedIndex = 27; };",
"}",
"if (((lmp_month_value == 3) || (lmp_month_value == 5) || (lmp_month_value == 8) || (lmp_month_value == 10)) && (lmp_date_value > 30)){ lmp_date_value = 30; lmp_date.selectedIndex = 29; };",
"lmp_time.setFullYear(lmp_year_value);",
"lmp_time.setMonth(lmp_month_value, lmp_date_value);",
"lmp_time.setHours(0);",
"edd_lmp.setTime(lmp_time.getTime() + 24192000000);",
"edd_lmp_result.value = monthname[edd_lmp.getMonth()] + ' ' + edd_lmp.getDate() + ', ' + edd_lmp.getFullYear();",
"lmpmillis = current_time.getTime() - lmp_time.getTime();",
"lmpweeks = fixDP(lmpmillis / 604800000, 1);",
"lmpweeksfloor = Math.floor(lmpweeks);",
"lmpdays =  Math.round(7 * (lmpweeks - lmpweeksfloor));",
"daystxt = ' days';",
"if (lmpdays == 1) daystxt = ' day';",
"if ((lmp_year_value >= 0) && (lmp_month_value >= 0) && (lmp_date_value >= 0)){ current_gest_lmp.value = lmpweeksfloor + ' weeks' + ' ' + lmpdays + daystxt; }",
"else{ current_gest_lmp.value = ''; edd_lmp_result.value = '';}",
"var us_month_value = parseFloat(us_month.options[us_month.selectedIndex].value);",
"var us_date_value = parseFloat(us_date.options[us_date.selectedIndex].value);",
"var us_year_value = parseFloat(us_year.options[us_year.selectedIndex].value);",
"if ((us_month_value == 1) && (us_date_value > 28)){",
"if ((us_year_value % 4) == 0){ us_date_value = 29; us_date.selectedIndex = 28; }",
"else{ us_date_value = 28; us_date.selectedIndex = 27; };",
"}",
"if (((us_month_value == 3) || (us_month_value == 5) || (us_month_value == 8) || (us_month_value == 10)) && (us_date_value > 30)){ us_date_value = 30; us_date.selectedIndex = 29; };",
"us_time.setFullYear(us_year_value);",
"us_time.setMonth(us_month_value, us_date_value);",
"us_time.setHours(0);",
"if (Gestational_Age_by_US && (us_year_value >= 0) && (us_month_value >= 0) && (us_date_value >= 0)){",
"edd_us.setTime(us_time.getTime() - (Gestational_Age_by_US * 604800000 ) + 24192000000);",
"edd_us_result.value = monthname[edd_us.getMonth()] + ' ' + edd_us.getDate() + ', ' + edd_us.getFullYear();",
"usmillis = 24192000000 - (edd_us.getTime() - current_time.getTime());",
"usweeks = fixDP(usmillis / 604800000, 1);",
"usweeksfloor = Math.floor(usweeks);",
"usdays =  Math.round(7 * (usweeks - usweeksfloor));",
"daystxt = ' days';",
"if (usdays == 1) daystxt = ' day';",
"current_gest_us.value = usweeksfloor + ' weeks' + ' ' + usdays + daystxt;",
"}",
"else { edd_us_result.value = ''; current_gest_us.value = '';};",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.EstimatedDateDelivery_form){",
"",
"if (Gestational_Age_by_US_param.value && isNaN(Gestational_Age_by_US_param.value)){ Gestational_Age_by_US_param.value = ''; alertNaN(); }",
"if (Gestational_Age_by_US_param.value && Gestational_Age_by_US < 2) {",
"Gestational_Age_by_US = 0;",
"Gestational_Age_by_US_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Gestational Age by US is 2 weeks.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Gestational_Age_by_US_param.value && Gestational_Age_by_US > 40) {",
"Gestational_Age_by_US_param.value = \"\";",
"clrResults();",
"Gestational_Age_by_US = 0;",
"doCalc = false;",
"alert(\"The maximum value for Gestational Age by US is 40 weeks.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.EstimatedDateDelivery_form){",
"",
"current_gest_lmp.value = '';",
"edd_lmp_result.value = '';",
"current_gest_us.value = '';",
"edd_us_result.value = '';",
"",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
""].join("\n");
var outline_f41_5_42067=null;
var title_f41_5_42068="Middle ear CT axial view";
var content_f41_5_42068=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F72168&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F72168&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Middle ear CT scan",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial cuts of a computed tomography (CT) scan demonstrating traumatic ossicular disruption of the malleo-incudal joint. Note the hypodense space between the malleus and incus that represents a joint separation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Adele Karen Evans, MD, FAAP and Steven D Handler MD, MBE.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42068=[""].join("\n");
var outline_f41_5_42068=null;
var title_f41_5_42069="Pomalidomide: Patient drug information";
var content_f41_5_42069=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Pomalidomide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/33/33303?source=see_link\">",
"     see \"Pomalidomide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F16226145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Pomalyst&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F16238618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700280",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects. Women must use 2 helpful kinds of birth control during care. A man must use a latex condom even if he has had a vasectomy. A written explanation of the risks must be presented, read, and signed by the patient before getting this drug. If a patient is younger than 18 years of age, this written warning must be signed by a parent or legal guardian.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause blood clots in your veins or lungs. Call your doctor right away if you have any chest pain, shortness of breath, or pain or swelling of the legs or arms.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4175203",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may only get this drug with the POMALYST REMS&trade; program.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F16238620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691968",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat multiple myeloma.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F16238619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4175182",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to pomalidomide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701068",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are of childbearing age, but are not using 2 kinds of birth control or if you are planning to get pregnant during your care or within 4 weeks after care has ended.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F16238623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696742",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not donate blood while using this drug and for 1 month after stopping.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697355",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you smoke, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697770",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use 2 kinds of birth control that you can trust before care begins, during care, and for 4 weeks after care ends.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Birth control pills and other hormone-based birth control may not work to stop pregnancy. Use 2 kinds of birth control while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697026",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, use a latex condom even if you have had a vasectomy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697052",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man, do not donate sperm while using this drug and for 1 month after stopping.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F16238624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697883",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Back pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698081",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697905",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood clots may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698278",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nerve problems may happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F16238625\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698719",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think you have a blood clot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F16238621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 2 hours before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698521",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a woman of childbearing age, take a pregnancy test before starting this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F16238622\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2821639",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it has been less than 12 hours since a normal dose, take a missed dose as soon as you think about it and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696587",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it has been 12 hours or more since the missed dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F16238626\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F16238627\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 88425 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-66B715A8D5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42069=[""].join("\n");
var outline_f41_5_42069=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16226145\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16238618\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16238620\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16238619\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16238623\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16238624\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16238625\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16238621\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16238622\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16238626\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16238627\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?32/33/33303?source=related_link\">",
"      Pomalidomide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_5_42070="Enhanced cardiac automaticity";
var content_f41_5_42070=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"15\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Enhanced cardiac automaticity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42070/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42070/contributors\">",
"     Philip J Podrid, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42070/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42070/contributors\">",
"     Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42070/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42070/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/5/42070/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 4, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enhanced cardiac automaticity refers to the accelerated generation of an action potential by either normal pacemaker tissue (enhanced normal automaticity) or by abnormal tissue within the myocardium (abnormal automaticity). The discharge rate of normal or abnormal pacemakers may be accelerated by drugs, various forms of cardiac disease, reduction in extracellular potassium, or alterations of autonomic nervous system tone. Enhanced normal automaticity accounts for the occurrence of sinus tachycardia, while abnormal automaticity may result in various atrial or ventricular arrhythmias, for example, an accelerated idioventricular rhythm.",
"   </p>",
"   <p>",
"    This topic will review the physiologic principles underlying both enhanced normal automaticity and automatic automaticity. The diagnosis and treatment of arrhythmias resulting from enhanced cardiac automaticity are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/25/14742?source=see_link\">",
"     \"Sinus tachycardia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ENHANCED NORMAL AUTOMATICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enhanced normal automaticity is best understood by beginning with a brief review of the physiology and hierarchy of stimulation of normal cardiac automaticity. This will be followed by a discussion of the electrophysiologic principles underlying the normal and enhanced automaticity of the SA node, the subsidiary atrial pacemakers, the atrioventricular (AV) node, and the ventricles.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Normal automaticity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal automaticity involves the slow, progressive depolarization of the membrane potential (spontaneous diastolic depolarization or phase four depolarization) until a threshold potential is reached, at which point an action potential (",
"    <a class=\"graphic graphic_figure graphicRef64133 \" href=\"mobipreview.htm?26/24/27023\">",
"     figure 1",
"    </a>",
"    ) is initiated. Although automaticity is an intrinsic property of all myocardial cells, the occurrence of spontaneous activity is prevented by the natural hierarchy of pacemaker function. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/33/38422?source=see_link\">",
"     \"Myocardial action potential and action of antiarrhythmic drugs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The spontaneous discharge rate of the sinoatrial (SA) nodal complex exceeds that of all other subsidiary or latent pacemakers. As a result, the impulse initiated by the SA node depresses the activity of subsidiary pacemaker sites, before they can spontaneously depolarize to threshold. However, slowly depolarizing and previously suppressed pacemakers in the atrium, AV node, or ventricle can become active and assume pacemaker control of the cardiac rhythm if the SA node pacemaker becomes slow or unable to generate an impulse or if impulses generated by the SA node are unable to activate the surrounding atrial myocardium. The emergence of subsidiary or latent pacemakers under such circumstances is an appropriate fail-safe mechanism which assures that ventricular activation is maintained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     SA node",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ionic mechanisms responsible for normal pacemaker activity in the SA node have not been conclusively defined, but are likely the result of a hyperpolarization-activated inward current and decay of outward potassium currents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/1\">",
"     1",
"    </a>",
"    ]. This progressive net gain of positive charge underlies the spontaneous diastolic depolarization of SA node cells which results from the following sequence of events (",
"    <a class=\"graphic graphic_figure graphicRef70961 \" href=\"mobipreview.htm?24/41/25232\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During the first third of diastolic depolarization, the inward leak of sodium ions is coupled with a time-dependent decrease in the outward potassium current.",
"     </li>",
"     <li>",
"      During the latter two thirds of depolarization, a slow inward movement of calcium ions occurs. This process moves the membrane potential to the threshold potential, at which time there is a more rapid inward calcium current, generating a slow action potential.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Effects of drugs and autonomic tone on the SA node",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drugs and autonomic neurotransmitters perturb these currents, thereby altering the SA node discharge rate. As an example, agents and neurotransmitters that accelerate the sinus node discharge rate bind to the beta adrenergic receptor, leading to an increase in the inward movement of calcium due to the phosphorylation of a protein that modulates the",
"    <strong>",
"     opening of calcium channels",
"    </strong>",
"    &nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef68194 \" href=\"mobipreview.htm?24/8/24704\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The ensuing influx of calcium accelerates the rate of diastolic depolarization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parasympathetic tone, on the other hand, reduces the spontaneous discharge rate of the SA node, while its withdrawal accelerates SA node automaticity. Acetylcholine, the principle neurotransmitter of the parasympathetic nervous system, inhibits spontaneous impulse generation in the SA node by",
"    <strong>",
"     increasing potassium conductance",
"    </strong>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/3\">",
"     3",
"    </a>",
"    ]. The resulting hyperpolarization of the membrane potential lengthens the time required for the membrane potential to depolarize to threshold, thereby decreasing the automaticity of the SA node.",
"   </p>",
"   <p>",
"    In addition to altering ionic conductance, changes in autonomic tone can also produce changes in the rate of the SA node by",
"    <strong>",
"     shifting the primary pacemaker region",
"    </strong>",
"    within the pacemaker complex, which is described as a cylindrical crescent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/6\">",
"     6",
"    </a>",
"    ]. Intrinsic discharge frequencies vary within different regions of the SA node; the discharge rate is faster in the cranial portion of the node, while it is slower in the caudal region. As a result, autonomically-mediated shifts of pacemaker regions may be accompanied by changes in the sinus rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Vagal fibers are more dense in the cranial portion of the SA node and stimulation of the parasympathetic nervous system shifts the pacemaker center to a more caudal region of the SA nodal complex, resulting in slowing of the heart rate, whereas stimulation of the sympathetic nervous system or withdrawal of vagal stimulation shifts the pacemaker center cranially, resulting in an increase in heart rate (",
"    <a class=\"graphic graphic_figure graphicRef55214 \" href=\"mobipreview.htm?18/0/18433\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The following are examples of stimuli which can alter the automaticity of the SA node:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Exercise, which augments sympathetic tone, enhances normal automaticity in the SA node and can produce sinus tachycardia (heart rates exceeding 100",
"      <span class=\"nowrap\">",
"       beats/minute).",
"      </span>",
"     </li>",
"     <li>",
"      Respiratory sinus arrhythmia (respirophasic arrhythmia) is primarily caused by withdrawal of vagal tone during inspiration and by reinstitution of vagal tone during expiration. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/2/2086?source=see_link\">",
"       \"Normal sinus rhythm and sinus arrhythmia\"",
"      </a>",
"      .) These alterations in vagal tone are mediated by peripheral sensors linked to arterial chemoreceptors and baroreceptors, intracardiac reflexes, and pulmonary stretch receptors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/9-11\">",
"       9-11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Digitalis has a well known positive chronotropic effect on the SA node, caused by depolarization of the membrane potential due to inhibition of the Na-K-ATPase pump [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/9,12\">",
"       9,12",
"      </a>",
"      ]. The reduction in the maximum diastolic membrane potential decreases the time required for the membrane to depolarize to threshold, thereby accelerating the spontaneous discharge rate.",
"     </li>",
"     <li>",
"      Beta blockers, which block the effect of sympathetic stimulation and circulating catecholamines on the SA node, result in a reduction in its normal automaticity. However, their effect at rest is less marked, as normal resting SA nodal function is not dependent upon sympathetic stimulation but is mediated more by vagal tone. However, during times of sympathetic stimulation, these agents will blunt the acceleration in heart rate.",
"     </li>",
"     <li>",
"      Calcium channel blockers, especially",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"       verapamil",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/16/12554?source=see_link\">",
"       diltiazem",
"      </a>",
"      , reduce the influx of calcium ions, and therefore will reduce the rate of diastolic depolarization and hence the rate of SA nodal discharge.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Subsidiary atrial pacemakers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Latent atrial pacemakers have been identified in the atrial myocardium (especially the crista terminalis), coronary sinus, and AV valves [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/13-17\">",
"     13-17",
"    </a>",
"    ], while ectopic atrial pacemakers have been identified in the region around the pulmonary veins [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/18\">",
"     18",
"    </a>",
"    ]. They may responsible for precipitating atrial fibrillation and their elimination or isolation with radiofrequency catheter ablation has been found to be effective for the prevention of paroxysmal atrial fibrillation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/62/40938?source=see_link\">",
"     \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Latent atrial pacemakers may be expected to contribute to impulse initiation in the atrium if the discharge rate of the SA node is reduced temporarily or permanently. In contrast to the normal pacemaker tissue, these latent or ectopic pacemakers usually generate a fast action potential, mediated by sodium ion fluxes. However, when severely damaged, the atrial tissue may not be able to generate a fast action potential (which is energy-dependent) but rather generates a slow, calcium ion-mediated action potential (which is energy-independent).",
"   </p>",
"   <p>",
"    Automaticity of subsidiary atrial pacemakers may also be enhanced by coronary disease and ischemia, chronic pulmonary disease, or drugs such as digitalis and alcohol, possibly overriding normal SA node activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/9,20,21\">",
"     9,20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     AV junction",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is uncertain if the AV node itself has pacemaker cells, but it is clear that the AV junction, which is an area that includes atrial tissue, the AV node and His-Purkinje tissue, does have pacemaker cells and is capable of exhibiting automaticity. Automaticity of the AV junction appears to arise via a mechanism similar to that which occurs in the SA node [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. Diastolic depolarization is caused by a gradual decrease in the outward potassium current and an increase in the inward movement of calcium ions. Acceleration of AV nodal automaticity by beta-adrenergic agonists is believed to result from activation of the calcium channel, resulting in an increased inward calcium current, similar to that induced in the SA node.",
"   </p>",
"   <p>",
"    Ectopic AV nodal tachycardias due to enhanced automaticity have the following clinical features:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Marked sinus bradycardia or SA node exit block can result in an escape AV nodal or junctional rhythm.",
"     </li>",
"     <li>",
"      The emergence of an AV junctional rhythm is usually characterized by a gradual increase in spontaneous discharge rate (a warm-up phenomenon) until a reasonably regular rate of 35 to 60 beats per minute is attained [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Acceleration of the AV junctional rate to 70 to 130 beats per minute (junctional tachycardia) can occur with an inferior myocardial infarction, open heart surgery, myocarditis, digitalis intoxication, or sympathetic activation.",
"     </li>",
"     <li>",
"      The onset and termination of accelerated junctional tachycardias are usually gradual (ie, nonparoxysmal).",
"     </li>",
"     <li>",
"      The tachycardia rate is slowed by enhanced vagal tone and is accelerated by vagolytic or sympathomimetic agents.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Ventricle",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated cells of the His-Purkinje system discharge spontaneously at rates of 15 to 60 beats per minute, whereas ventricular myocardial cells usually do not exhibit spontaneous diastolic depolarization or automaticity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. The relatively slow spontaneous discharge rate of Purkinje fibers ensures that pacemaker activity in the His-Purkinje system will be suppressed on a beat-to-beat basis by the more rapid discharge rate of the SA node [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Under normal conditions the Purkinje fibers do not exhibit spontaneous automaticity because of \"overdrive suppression\" by more proximal pacemakers (ie, sinus and atrioventricular node) that have a faster discharge rate (",
"    <a class=\"graphic graphic_figure graphicRef61185 \" href=\"mobipreview.htm?33/22/34145\">",
"     figure 5",
"    </a>",
"    ). However, enhanced Purkinje fiber automaticity can be induced by certain situations, such as a myocardial infarction. In this setting, some Purkinje fibers which survive the infarction have moderately reduced maximum diastolic membrane potentials and therefore accelerated spontaneous discharge rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/29-35\">",
"     29-35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ABNORMAL AUTOMATICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enhanced automaticity of the SA node, subsidiary atrial pacemakers, or the AV node due to a mechanism other than acceleration of normal automaticity has",
"    <strong>",
"     not",
"    </strong>",
"    been demonstrated clinically. However, abnormal automaticity of Purkinje fibers and atrial and ventricular tissue can occur.",
"   </p>",
"   <p>",
"    As noted above, isolated cardiac Purkinje fibers usually have relatively slow spontaneous discharge rates, whereas atrial and ventricular muscle are quiescent. However, depolarization of these tissues by a disease process, in particular acute myocardial ischemia, can induce spontaneous activity. This automaticity is not suppressed by overdrive pacing, is more easily suppressed by calcium channel blockade than by sodium channel blockade, and is accelerated by beta-adrenergic agonists [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/34-39\">",
"     34-39",
"    </a>",
"    ]. Thus, abnormal automaticity in these tissues resembles normal automaticity in the sinus and AV nodes (ie, results from a time dependent decay of outward potassium currents and progressive activation of inward calcium currents) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acceleration of Purkinje fiber automaticity can also be augmented by the elevated levels of catecholamines and increased sympathetic tone which occurs during ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/42\">",
"     42",
"    </a>",
"    ]. Purkinje fibers surviving myocardial infarction appear to be more sensitive to the positive chronotropic effects of catecholamines than normal Purkinje fibers, perhaps because of denervation supersensitivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There appears to be an association between abnormal Purkinje fiber automaticity and the arrhythmias that occur during the acute phase of myocardial infarction, for example, an accelerated idioventricular rhythm. However, the role of abnormal automaticity in the development of ventricular arrhythmias associated with chronic ischemic heart disease is less certain. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/17/12570?source=see_link\">",
"     \"Pathogenesis of ventricular tachycardia and ventricular fibrillation during acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Isolated myocytes obtained from hypertrophied and failing hearts have been shown to manifest spontaneous diastolic depolarization and enhanced pacemaker currents, suggesting that abnormal automaticity may contribute to the occurrence of some arrhythmias in heart failure and left ventricular hypertrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42070/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. It has been shown that stretch of the myocardium can increase its automaticity (ie, electromechanical feedback). This may account for arrhythmias that are seen with heart failure and acute dilation of the atrial or ventricular myocardium. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/17/14615?source=see_link\">",
"     \"Pathogenesis of ventricular arrhythmias in heart failure and cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/23/1401?source=see_link\">",
"     \"Left ventricular hypertrophy and arrhythmia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some of the arrhythmias that occur with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    toxicity may be related to enhanced automaticity, although this is not firmly established since delayed potentials and triggered automaticity is another potential mechanism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/26/28072?source=see_link\">",
"     \"Basic approach to arrhythmias due to digoxin toxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The role of abnormal automaticity in the genesis of other clinical arrhythmias has generally not been established. Although automaticity is not responsible for most clinical tachyarrhythmias, which are usually due to a reentry, it may certainly precipitate or trigger any reentrant arrhythmia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H123140\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Enhanced cardiac automaticity refers to the accelerated generation of an action potential by either normal pacemaker tissue (enhanced normal automaticity) or by abnormal tissue within the myocardium (abnormal automaticity). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The spontaneous discharge rate of the sinoatrial (SA) nodal complex exceeds that of all other subsidiary or latent pacemakers, thereby depressing the activity of subsidiary pacemaker sites before they can spontaneously depolarize to threshold. However, previously suppressed pacemakers in the atrium, AV node, or ventricle can assume pacemaker control of the cardiac rhythm if the SA node pacemaker becomes slow or unable to generate an impulse or if impulses generated by the SA node are unable to activate the surrounding atrial myocardium. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Normal automaticity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Drugs and autonomic neurotransmitters alter the SA node discharge rate (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Effects of drugs and autonomic tone on the SA node'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Increased sympathetic input or withdrawal of parasympathetic input (eg, exercise, beta agonist medications) results in higher sinus rates.",
"     </li>",
"     <li>",
"      Decreased sympathetic input or increased parasympathetic input (eg, beta blockers,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"       digoxin",
"      </a>",
"      ) leads to lower sinus rates.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The AV junction, an area that includes atrial tissue, the AV node, and His-Purkinje tissue, contains pacemaker cells and is capable of exhibiting automaticity, which may result in ectopic AV nodal tachycardias. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'AV junction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Isolated cells of the His-Purkinje system discharge spontaneously at rates of 15 to 60 beats per minute, whereas ventricular myocardial cells usually do not exhibit spontaneous diastolic depolarization or automaticity. Under normal conditions, the Purkinje fibers do not exhibit spontaneous automaticity because of suppression by more proximal pacemakers that have a faster discharge rate. However, enhanced Purkinje fiber automaticity can be induced by certain situations, such as a myocardial infarction. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Ventricle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There appears to be an association between abnormal Purkinje fiber automaticity and the arrhythmias that occur during the acute phase of myocardial infarction, for example, an accelerated idioventricular rhythm. However, the role of abnormal automaticity in the development of ventricular arrhythmias associated with chronic ischemic heart disease is less certain. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Abnormal automaticity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/1\">",
"      DiFrancesco D. The pacemaker current (I(f)) plays an important role in regulating SA node pacemaker activity. Cardiovasc Res 1995; 30:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/2\">",
"      Irisawa H, Hagiwara N. Ionic current in sinoatrial node cells. J Cardiovasc Electrophysiol 1991; 2:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/3\">",
"      Brown HF. Electrophysiology of the sinoatrial node. Physiol Rev 1982; 62:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/4\">",
"      Reuter H. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 1983; 301:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/5\">",
"      Kameyama M, Hofmann F, Trautwein W. On the mechanism of beta-adrenergic regulation of the Ca channel in the guinea-pig heart. Pflugers Arch 1985; 405:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/6\">",
"      Boineau JP, Canavan TE, Schuessler RB, et al. Demonstration of a widely distributed atrial pacemaker complex in the human heart. Circulation 1988; 77:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/7\">",
"      Bouman LN, Gerlings ED, Biersteker PA, Bonke FI. Pacemaker shift in the sino-atrial node during vagal stimulation. Pflugers Arch 1968; 302:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/8\">",
"      Goldberg JM. Intra-SA-nodal pacemaker shifts induced by autonomic nerve stimulation in the dog. Am J Physiol 1975; 229:1116.",
"     </a>",
"    </li>",
"    <li>",
"     Zipes DP. Specific arrhythmias: diagnosis and treatment. In: Heart Disease: A Textbook of Cardiovascular Medicine, Braunwald E (Ed), Saunders, Philadelphia 1992. p.667.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/10\">",
"      Eckberg DL. Human sinus arrhythmia as an index of vagal cardiac outflow. J Appl Physiol 1983; 54:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/11\">",
"      Grossman P, Kollai M. Respiratory sinus arrhythmia, cardiac vagal tone, and respiration: within- and between-individual relations. Psychophysiology 1993; 30:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/12\">",
"      Steinbeck G, Bonke FI, Allessie MA, Lammers WJ. The effect of ouabain on the isolated sinus node preparation of the rabbit studied with microelectrodes. Circ Res 1980; 46:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/13\">",
"      Wit AL, Cranefield PF. Triggered and automatic activity in the canine coronary sinus. Circ Res 1977; 41:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/14\">",
"      Jones SB, Euler DE, Randall WC, et al. Atrial ectopic foci in the canine heart: hierarchy of pacemaker automaticity. Am J Physiol 1980; 238:H788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/15\">",
"      Wit AL, Fenoglio JJ Jr, Wagner BM, Bassett AL. Electrophysiological properties of cardiac muscle in the anterior mitral valve leaflet and the adjacent atrium in the dog. Possible implications for the genesis of atrial dysrhythmias. Circ Res 1973; 32:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/16\">",
"      Hogan PM, Davis LD. Evidence for specialized fibers in the canine right atrium. Circ Res 1968; 23:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/17\">",
"      James TN, Sherf L, Fine G, Morales AR. Comparative ultrastructure of the sinus node in man and dog. Circulation 1966; 34:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/18\">",
"      Ha&iuml;ssaguerre M, Ja&iuml;s P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/19\">",
"      Chen SA, Hsieh MH, Tai CT, et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999; 100:1879.",
"     </a>",
"    </li>",
"    <li>",
"     Swerdlow CD, Liem LB. Atrial and junctional tachycardias: clinical presentation, course and therapy. In: Cardiac Electrophysiology. From Cell to Bedside, Zipes,DP, Jalife J (Eds), Saunders, Philadelphia 1990. p.742.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/21\">",
"      Goldreyer BN, Gallagher JJ, Damato AN. The electrophysiologic demonstration of atrial ectopic tachycardia in man. Am Heart J 1973; 85:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/22\">",
"      Kokubun S, Nishimura M, Noma A, Irisawa H. The spontaneous action potential of rabbit atrioventricular node cells. Jpn J Physiol 1980; 30:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/23\">",
"      Noma A, Irisawa H, Kokobun S, et al. Slow current systems in the A-V node of the rabbit heart. Nature 1980; 285:228.",
"     </a>",
"    </li>",
"    <li>",
"     Watanabe Y, Nishimura M, Noda T, et al. Atrioventricular junctional tachycardias. In: Cardiac Electrophysiology. From Cell to Bedside, Zipes DP, Jalife J (Eds), Saunders, Philadelphia 1990. p.564.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/25\">",
"      DiFrancesco D. A new interpretation of the pace-maker current in calf Purkinje fibres. J Physiol 1981; 314:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/26\">",
"      Hirano Y, Hiraoka M. Barium-induced automatic activity in isolated ventricular myocytes from guinea-pig hearts. J Physiol 1988; 395:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/27\">",
"      Vassalle M. The relationship among cardiac pacemakers. Overdrive suppression. Circ Res 1977; 41:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/28\">",
"      Vassalle M. Electrogenic suppression of automaticity in sheep and dog purkinje fibers. Circ Res 1970; 27:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/29\">",
"      Allen JD, Brennan FJ, Wit AL. Actions of lidocaine on transmembrane potentials of subendocardial Purkinje fibers surviving in infarcted canine hearts. Circ Res 1978; 43:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/30\">",
"      Friedman PL, Stewart JR, Wit AL. Spontaneous and induced cardiac arrhythmias in subendocardial Purkinje fibers surviving extensive myocardial infarction in dogs. Circ Res 1973; 33:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/31\">",
"      Lazzara R, el-Sherif N, Scherlag BJ. Electrophysiological properties of canine Purkinje cells in one-day-old myocardial infarction. Circ Res 1973; 33:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/32\">",
"      Dangman KH, Danilo P Jr, Hordof AJ, et al. Electrophysiologic characteristics of human ventricular and Purkinje fibers. Circulation 1982; 65:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/33\">",
"      Horowitz LN, Spear JF, Moore EN. Subendocardial origin of ventricular arrhythmias in 24-hour-old experimental myocardial infarction. Circulation 1976; 53:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/34\">",
"      Imanishi S. Calcium-sensitive discharges in canine Purkinje fibers. Jpn J Physiol 1971; 21:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/35\">",
"      Imanishi S, Surawicz B. Automatic activity in depolarized guinea pig ventricular myocardium. Characteristics and mechanisms. Circ Res 1976; 39:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/36\">",
"      Grant AO, Katzung BG. The effects of quinidine and verapamil on electrically induced automaticity in the ventricular myocardium of guinea pig. J Pharmacol Exp Ther 1976; 196:407.",
"     </a>",
"    </li>",
"    <li>",
"     Elharrar V, Zipes DP. Voltage modulation of automaticity in cardiac Purkinje fibers. In: The slow inward current and cardiac arrhythmias, Zipes DP, Bailey JC, Elharrar V (Eds), Martinus Nijhoff, The Hague 1980. p.357.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/38\">",
"      Katzung BG. Effects of extracellular calcium and sodium on depolarization-induced automaticity in guinea pig papillary muscle. Circ Res 1975; 37:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/39\">",
"      Pappano AJ, Carmeliet EE. Epinephrine and the pacemaking mechanism at plateau potentials in sheep cardiac Purkinje fibers. Pflugers Arch 1979; 382:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/40\">",
"      Hauswirth O, Noble D, Tsien RW. The mechanism of oscillatory activity at low membrane potentials in cardiac Purkinje fibres. J Physiol 1969; 200:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/41\">",
"      Katzung BG, Morgenstern JA. Effects of extracellular potassium on ventricular automaticity and evidence for a pacemaker current in mammalian ventricular myocardium. Circ Res 1977; 40:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/42\">",
"      Ceremuzy��ski L, Staszewska-Barczak J, Herbaczynska-Cedro K. Cardiac rhythm disturbances and the release of catecholamines after acute coronary occlusion in dogs. Cardiovasc Res 1969; 3:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/43\">",
"      Cameron JS, Han J. Effects of epinephrine on automaticity and the incidence of arrhythmias in Purkinje fibers surviving myocardial infarction. J Pharmacol Exp Ther 1982; 223:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/44\">",
"      Barber MJ, Mueller TM, Henry DP, et al. Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 1983; 67:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/45\">",
"      Nuss HB, K&auml;&auml;b S, Kass DA, et al. Cellular basis of ventricular arrhythmias and abnormal automaticity in heart failure. Am J Physiol 1999; 277:H80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42070/abstract/46\">",
"      Hoppe UC, Jansen E, S&uuml;dkamp M, Beuckelmann DJ. Hyperpolarization-activated inward current in ventricular myocytes from normal and failing human hearts. Circulation 1998; 97:55.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 952 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-197.136.42.3-AB557005D7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42070=[""].join("\n");
var outline_f41_5_42070=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H123140\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ENHANCED NORMAL AUTOMATICITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Normal automaticity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SA node",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Effects of drugs and autonomic tone on the SA node",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Subsidiary atrial pacemakers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      AV junction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Ventricle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ABNORMAL AUTOMATICITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H123140\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/952\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/952|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/24/27023\" title=\"figure 1\">",
"      Action potential and ECG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/41/25232\" title=\"figure 2\">",
"      Slow action potential",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/8/24704\" title=\"figure 3\">",
"      Ca channel sympathetic activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/0/18433\" title=\"figure 4\">",
"      Sinus node pacemaker sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?33/22/34145\" title=\"figure 5\">",
"      Overdrive pacing",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/26/28072?source=related_link\">",
"      Basic approach to arrhythmias due to digoxin toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/23/1401?source=related_link\">",
"      Left ventricular hypertrophy and arrhythmia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/33/38422?source=related_link\">",
"      Myocardial action potential and action of antiarrhythmic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/2/2086?source=related_link\">",
"      Normal sinus rhythm and sinus arrhythmia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/17/14615?source=related_link\">",
"      Pathogenesis of ventricular arrhythmias in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/17/12570?source=related_link\">",
"      Pathogenesis of ventricular tachycardia and ventricular fibrillation during acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/62/40938?source=related_link\">",
"      Radiofrequency catheter ablation to prevent recurrent atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/25/14742?source=related_link\">",
"      Sinus tachycardia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_5_42071="Overview of Candida infections";
var content_f41_5_42071=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of Candida infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42071/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42071/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42071/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42071/contributors\">",
"     Kieren A Marr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42071/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42071/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/5/42071/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of infection with Candida species range from local mucous membrane infections to widespread dissemination with multisystem organ failure. Although Candida are considered normal flora in the gastrointestinal and genitourinary tracts of humans, they have the propensity to invade and cause disease when an imbalance is created in the ecologic niche in which these organisms usually exist. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/19/37176?source=see_link\">",
"     \"Biology of Candida infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The immune response of the host is an important determinant of the type of infection caused by Candida.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most benign infections are characterized by local overgrowth on mucous membranes (oropharyngeal involvement, vaginitis) as a result of changes in the normal flora. More extensive persistent mucous membrane infections occur in individuals with deficiencies in cell-mediated immunity, such as AIDS.",
"     </li>",
"     <li>",
"      Invasive focal infections, such as pyelonephritis, endocarditis, and meningitis, most often occur after hematogenous spread or when anatomic abnormalities or devices (eg, prosthetic heart valves or central nervous system shunts) are present.",
"     </li>",
"     <li>",
"      In the neutropenic host or the severely ill patient in the intensive care unit, widespread visceral dissemination occurs when Candida species gain access to the bloodstream.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The different Candida species generally are capable of producing all of the clinical syndromes, although infection with Candida albicans is the most common. It is important to identify the infecting organism because some species are more resistant to the azole antifungal agents than others. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29914?source=see_link\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will provide a broad overview of the various manifestations of Candida infection. Infection at most of these sites is discussed in detail in other topic reviews and will be only briefly summarized here. The treatment of Candida infections is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29914?source=see_link\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=see_link\">",
"     \"Candida vulvovaginitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40566?source=see_link\">",
"     \"Candida endocarditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39559?source=see_link\">",
"     \"Candida infections of the central nervous system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/25/11671?source=see_link\">",
"     \"Candida osteoarticular infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/12/39112?source=see_link\">",
"     \"Treatment of endogenous endophthalmitis due to Candida species\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/16/36102?source=see_link\">",
"     \"Treatment of exogenous endophthalmitis due to Candida species\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/49/15128?source=see_link\">",
"     \"Candida infections of the bladder and kidneys\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10071?source=see_link\">",
"     \"Hepatosplenic candidiasis (chronic disseminated candidiasis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LOCAL MUCOCUTANEOUS INFECTIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Oropharyngeal candidiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oropharyngeal candidiasis, or thrush, is a common local infection seen in infants; older adults who wear dentures; patients treated with antibiotics, chemotherapy, or radiation therapy to the head and neck; and those with cellular immune deficiency states, such as AIDS. Patients with xerostomia and those treated with inhaled glucocorticoids for asthma or rhinitis are also at risk. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/17/29972?source=see_link\">",
"     \"Clinical manifestations of oropharyngeal and esophageal candidiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The usual symptoms of oropharyngeal candidiasis are a cottony feeling in the mouth, loss of taste, and sometimes pain on eating and swallowing. However, many patients are asymptomatic, whereas patients with denture stomatitis often have pain when they try to wear their dentures. Immunosuppressed patients with thrush often have concomitant Candida esophagitis.",
"   </p>",
"   <p>",
"    The diagnosis is usually suspected because of the presence of white plaques on the buccal mucosa, palate, tongue, or the oropharynx (",
"    <a class=\"graphic graphic_picture graphicRef75887 \" href=\"mobipreview.htm?5/12/5312\">",
"     picture 1",
"    </a>",
"    ) or under dentures, where there is usually erythema without plaques (",
"    <a class=\"graphic graphic_picture graphicRef79519 \" href=\"mobipreview.htm?7/32/7680\">",
"     picture 2",
"    </a>",
"    ). The diagnosis is readily confirmed by scraping the lesions with a tongue depressor and performing a Gram stain or KOH preparation on the scrapings. Budding yeasts with or without pseudohyphae are seen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Esophagitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal candidiasis is most common in HIV-infected patients, in which it is an AIDS-defining illness, and in patients with hematologic malignancies. Concomitant thrush may or may not be present. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/17/29972?source=see_link\">",
"     \"Clinical manifestations of oropharyngeal and esophageal candidiasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/38/4707?source=see_link\">",
"     \"Evaluation of the HIV-infected patient with odynophagia and dysphagia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The hallmark of Candida esophagitis is odynophagia or pain on swallowing. Patients usually localize their pain to a discrete retrosternal area. The diagnosis of Candida esophagitis is usually made when white mucosal plaque-like lesions are noted on endoscopy (",
"    <a class=\"graphic graphic_picture graphicRef65075 \" href=\"mobipreview.htm?9/43/9919\">",
"     picture 3",
"    </a>",
"    ). Confirmatory biopsy shows the presence of yeast and pseudohyphae invading mucosal cells, and culture reveals Candida.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Vulvovaginitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vulvovaginal candidiasis is the most common form of mucosal candidiasis. It most often occurs in situations associated with increased estrogen levels, such as oral contraceptive use and pregnancy. Antibiotics, glucocorticoids, diabetes mellitus, HIV infection, intrauterine devices, and diaphragm use are also risk factors. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=see_link\">",
"     \"Candida vulvovaginitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations of Candida vulvovaginitis are primarily itching and discharge. Dyspareunia, dysuria, and vaginal irritation also may be present. Physical examination shows vulvar erythema and swelling and vaginal erythema and discharge, which is classically white and curd-like but may be watery. Some patients, primarily those with C. glabrata infection, have little discharge and often only erythema on vaginal examination.",
"   </p>",
"   <p>",
"    The diagnosis of Candida vulvovaginitis is typically made clinically, but confirmation is easily obtained by observing budding yeast, with or without pseudohyphae, on a wet mount or KOH preparation of vaginal secretions (",
"    <a class=\"graphic graphic_picture graphicRef59030 \" href=\"mobipreview.htm?9/37/9809\">",
"     picture 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Balanitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Balanitis can present as white patches on the penis in association with severe burning and itching (",
"    <a class=\"graphic graphic_picture graphicRef65881 \" href=\"mobipreview.htm?12/10/12463\">",
"     picture 5",
"    </a>",
"    ). The infection can also spread to the thighs, gluteal folds, buttocks, and scrotum. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/33/14872?source=see_link\">",
"     \"Balanitis and balanoposthitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Chronic mucocutaneous candidiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic mucocutaneous candidiasis is a rare syndrome that usually has its onset in childhood. Some patients have autosomal recessive polyglandular autoimmune syndrome type I, which is also referred to as the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/0/40969?source=see_link&amp;anchor=H3#H3\">",
"     \"Causes of primary adrenal insufficiency (Addison's disease)\", section on 'Polyglandular autoimmune syndrome type I'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations of candidiasis in these patients include severe, recurrent thrush, onychomycosis, vaginitis, and chronic skin lesions. The skin lesions may assume a hyperkeratotic, crusted appearance on the face, scalp, and hands (",
"    <a class=\"graphic graphic_picture graphicRef64895 \" href=\"mobipreview.htm?10/1/10258\">",
"     picture 6",
"    </a>",
"    ). Visceral invasion is rare. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/1/22553?source=see_link\">",
"     \"Chronic mucocutaneous candidiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mastitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactating women with injured nipples are at increased risk for developing skin or breast infections, including candidal infections. The management of such infections is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/15/17658?source=see_link&amp;anchor=H14#H14\">",
"     \"Common problems of breastfeeding and weaning\", section on 'Candidal infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     RISK FACTORS FOR INVASIVE INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Invasive focal or systemic infections are most often associated with candidemia, which primarily occurs in immunosuppressed patients and those requiring intensive care. Immunosuppressed patients at special risk for candidemia include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Those with hematologic malignancies",
"     </li>",
"     <li>",
"      Recipients of solid organ or hematopoietic stem cell transplants",
"     </li>",
"     <li>",
"      Those given chemotherapeutic agents for a variety of different diseases",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Neutropenia is common in these settings, and most transplant recipients are also receiving glucocorticoids. Other risk factors in these patients include chemotherapeutic agents, especially those associated with extensive gastrointestinal mucosal damage, broad-spectrum antibiotics, and central venous catheters.",
"   </p>",
"   <p>",
"    Patients in intensive care units account for the greatest number of episodes of candidemia at most hospitals. Surgical units, especially those caring for trauma and burn patients, and neonatal units have the highest rates of Candida infections. Other risk factors commonly associated with invasive candidiasis in ICU patients include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Central venous catheters",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/40/42628?source=see_link\">",
"       Total parenteral nutrition",
"      </a>",
"     </li>",
"     <li>",
"      Broad-spectrum antibiotics",
"     </li>",
"     <li>",
"      High APACHE scores",
"     </li>",
"     <li>",
"      Acute renal failure, particularly if requiring hemodialysis",
"     </li>",
"     <li>",
"      Prior surgery, particularly abdominal surgery",
"     </li>",
"     <li>",
"      Gastrointestinal tract perforations and anastomotic leaks",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/48/37638?source=see_link&amp;anchor=H4#H4\">",
"     \"Epidemiology and pathogenesis of candidemia in adults\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CANDIDEMIA AND INVASIVE CANDIDIASIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candidemia refers to the presence of Candida species in the blood. Immunocompromised hosts and patients in intensive care units are at the highest risk of candidemia. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Risk factors for invasive infection'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The clinical manifestations vary from minimal fever to a full-blown sepsis syndrome indistinguishable from severe bacterial infection. Acute disseminated or invasive candidiasis occurs when visceral sites are infected as a result of hematogenous spread.",
"   </p>",
"   <p>",
"    Clinical clues to the occurrence of hematogenous spread of Candida include characteristic eye lesions, skin lesions, and less commonly, muscle abscesses. The skin lesions tend to appear suddenly as clusters of painless pustules on an erythematous base; they can occur on any area of the body. The lesions vary from tiny pustules that can be easily missed (",
"    <a class=\"graphic graphic_picture graphicRef55977 \" href=\"mobipreview.htm?33/63/34815\">",
"     picture 7",
"    </a>",
"    ) to others that are nodular, up to several centimeters in diameter, and may appear necrotic in the center (",
"    <a class=\"graphic graphic_picture graphicRef75717 \" href=\"mobipreview.htm?24/42/25248\">",
"     picture 8",
"    </a>",
"    ). In severely neutropenic patients, the lesions may be macular rather than pustular.",
"   </p>",
"   <p>",
"    Material obtained by scraping the base of a pustule with a scalpel blade shows yeast on Gram stain (",
"    <a class=\"graphic graphic_picture graphicRef70812 \" href=\"mobipreview.htm?34/21/35166\">",
"     picture 9",
"    </a>",
"    ), and, if enough material is obtained to perform a culture, this will yield Candida species. Alternatively, punch biopsies of skin lesions can be performed for histopathology and culture.",
"   </p>",
"   <p>",
"    In addition to these typical peripheral sites of involvement, signs of multiorgan system failure may be present. Autopsy studies reveal widespread visceral microabscesses that are especially prominent in the kidneys, heart, liver, spleen, lungs, eyes, and brain (",
"    <a class=\"graphic graphic_picture graphicRef52139 \" href=\"mobipreview.htm?37/49/38672\">",
"     picture 10",
"    </a>",
"    ). The clinical manifestations, diagnosis, and treatment of invasive Candida infections are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/6/36966?source=see_link\">",
"     \"Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29914?source=see_link\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     HEPATOSPLENIC OR CHRONIC DISSEMINATED CANDIDIASIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatosplenic candidiasis (also called chronic disseminated candidiasis) is seen almost entirely in patients with hematologic malignancies who have just recovered from an episode of neutropenia. Some patients have a documented prior episode of candidemia; in others, it is assumed that the patient was candidemic during the period of neutropenia. Invasion of Candida species through the portal vasculature has been proposed as another mechanism by which hepatosplenic candidiasis may occur in the absence of positive blood cultures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10071?source=see_link\">",
"     \"Hepatosplenic candidiasis (chronic disseminated candidiasis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The classic presentation of hepatosplenic candidiasis consists of persistent fever, which is frequently high and spiking, in a patient who was recently neutropenic and whose neutrophil count has returned to normal. The fever is often accompanied by right upper quadrant discomfort or pain, nausea, vomiting, and anorexia. Laboratory testing typically reveals an elevated serum alkaline phosphatase concentration. Discrete persistent microabscesses occur in the liver, spleen, and, sometimes, kidneys. The diagnosis can be established by visualizing multiple characteristic lucencies in the liver, spleen, and kidneys on ultrasound, magnetic resonance imaging, or CT scan (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61598 \" href=\"mobipreview.htm?26/63/27632\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     INVASIVE FOCAL INFECTIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Urinary tract infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Funguria is common in hospitalized patients, although it is often difficult to distinguish colonization from infection of the bladder. Candida infection of the bladder also must be distinguished from infection of the kidney, although the two entities can coexist. Invasive infection of the kidney is unusual and is more difficult to treat than infection of the bladder.",
"   </p>",
"   <p>",
"    Renal infection can be secondary to hematogenous seeding and is typically characterized by multiple microabscesses in the setting of disseminated candidiasis. Ascending infection develops more insidiously, is usually unilateral, and can be complicated by development of an obstructing bezoar or fungus ball. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/49/15128?source=see_link\">",
"     \"Candida infections of the bladder and kidneys\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Endophthalmitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida endophthalmitis can develop exogenously following trauma or eye surgery, or endogenously through hematogenous seeding of the retina and choroid as a complication of candidemia. Because of the risk of endophthalmitis from hematogenous seeding, the 2009 Infectious Diseases Society of America (IDSA) guidelines for the treatment of candidiasis recommend an early dilated retinal examination by an ophthalmologist in all candidemic patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42071/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/16/36102?source=see_link\">",
"     \"Treatment of exogenous endophthalmitis due to Candida species\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/12/39112?source=see_link\">",
"     \"Treatment of endogenous endophthalmitis due to Candida species\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The primary presenting symptom is a decrease in visual acuity; pain can sometimes occur. The classic findings of chorioretinal involvement are focal, glistening, white, infiltrative, often mound-like lesions on the retina (",
"    <a class=\"graphic graphic_picture graphicRef58685 \" href=\"mobipreview.htm?25/1/25630\">",
"     picture 11",
"    </a>",
"    ). When vitreous extension is present, a vitreal haze is present; sometimes fluffy white balls or \"snowballs\" in the vitreous are noted (",
"    <a class=\"graphic graphic_picture graphicRef73318 \" href=\"mobipreview.htm?24/39/25214\">",
"     picture 12",
"    </a>",
"    ). The infection can be sight-threatening if it is not treated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Osteoarticular infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida species infect bones and joints as a result of either hematogenous seeding or inoculation during trauma, intraarticular injection, a surgical procedure, or injection drug use. Although most infections have been described in native joints, prosthetic joints may also be affected. Among patients with osteomyelitis, the site of involvement varies with age. The vertebrae are most commonly involved in adults, while the long bones of the extremities are more likely to be involved in children. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/25/11671?source=see_link\">",
"     \"Candida osteoarticular infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Osteoarticular infections often become symptomatic months or as long as a year after an episode of fungemia or a surgical procedure and the manifestations are generally more subtle than bacterial infections at the same sites. Both of these factors contribute to long delays in diagnosis, especially in patients with vertebral osteomyelitis. The major symptoms of Candida arthritis are pain and decreased range of motion, whereas local pain is the predominant symptom of Candida osteomyelitis.",
"   </p>",
"   <p>",
"    The diagnosis is established by culture of the infected site. Candida arthritis is more easily confirmed than osteomyelitis, since synovial fluid can be readily obtained for culture. Even a single colony of Candida on culture of joint fluid or bone biopsy or aspirate should be viewed as pathogenic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Meningitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida infections of the central nervous system (CNS) most commonly involve the meninges. Candida meningitis can present as isolated chronic meningitis as a manifestation of disseminated candidiasis, which most often occurs in premature neonates, and as a complication of ventricular drainage devices, and as isolated chronic meningitis. In addition to hematogenous spread, Candida can enter the CNS at the time of craniotomy or through a ventriculoperitoneal or ventriculoatrial shunt. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39559?source=see_link\">",
"     \"Candida infections of the central nervous system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The symptoms of Candida meningitis can be the same as in acute bacterial meningitis (eg, fever, stiff neck, altered mental status, headache). However, signs of sepsis and multiorgan failure often predominate in neonates, and fever may be the only manifestation in patients who are neutropenic. In addition, patients with hematogenous seeding may also have other signs of dissemination, such as endophthalmitis, chorioretinitis, endocarditis, and skin or renal involvement. In each of these settings, lumbar puncture to obtain cerebrospinal fluid (CSF) for culture is essential to establish the diagnosis.",
"   </p>",
"   <p>",
"    The clinical features of chronic Candida meningitis resemble those of meningitis caused by tuberculosis or Cryptococcus species. Headache, fever, and nuchal rigidity are the most common manifestations. The diagnosis is difficult to establish because the organism is present in low numbers and the yield of standard cultures of CSF is poor. Large volume lumbar punctures are often required to obtain sufficient CSF for culture. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39559?source=see_link\">",
"     \"Candida infections of the central nervous system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/20/4424?source=see_link\">",
"     \"Approach to the patient with chronic meningitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida endocarditis is one of the most serious manifestations of candidiasis and is the most common cause of fungal endocarditis. Candida endocarditis results from candidemia and is usually seen in patients with prosthetic heart valves, in intravenous drug users, and in patients who have indwelling central venous catheters and prolonged fungemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40566?source=see_link\">",
"     \"Candida endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations of Candida endocarditis may be similar to those of bacterial endocarditis, including fever, changing or new heart murmurs, and signs and symptoms of heart failure. Peripheral embolization is more likely than with bacterial endocarditis, a probable reflection of larger vegetations, and affected patients can develop other complications of candidemia, such as visual loss secondary to endophthalmitis. In most patients, blood cultures reveal persistent candidemia and echocardiography shows vegetations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/24/41352?source=see_link\">",
"     \"Diagnostic approach to infective endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Peritonitis and intraabdominal infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida frequently contribute to polymicrobial infections that occur following gastrointestinal tract perforation, anastomotic leaks after bowel surgery, or acute necrotizing pancreatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42071/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. Discrete abscesses with or without peritonitis can occur. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/40/18055?source=see_link&amp;anchor=H2#H2\">",
"     \"Candida infections of the abdomen and thorax\", section on 'Peritonitis and intraabdominal infections'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Candida peritonitis can also complicate continuous peritoneal dialysis in patients with end-stage renal disease, which is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8631?source=see_link\">",
"     \"Fungal peritonitis in continuous peritoneal dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other intraabdominal manifestations of Candida infection include isolated pancreatic abscess, gangrenous cholecystitis, and obstruction to the common bile duct with a Candida fungus ball [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42071/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. C. albicans is the predominant species isolated in intraabdominal infections, but C. glabrata has assumed an increasing role at some centers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42071/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The symptoms of Candida peritonitis do not differ from those of bacterial peritonitis, which is often also present. Thus, fevers, chills, and abdominal pain are prominent. Complications include bloodstream invasion with sepsis and abscess formation requiring surgical drainage.",
"   </p>",
"   <p>",
"    The diagnosis is best made by aspiration of fluid under computed tomographic (CT) or ultrasound guidance or at the time of surgery. Culture of Candida species from an indwelling drain is not adequate for the diagnosis of infection, since it often reflects only colonization or contamination of the drain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumonia due to Candida is extremely rare. Furthermore, Candida pneumonia remains poorly defined as a clinical entity because positive cultures cannot distinguish between true infection and either colonization or contamination of samples with oropharyngeal contents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42071/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/40/18055?source=see_link&amp;anchor=H4#H4\">",
"     \"Candida infections of the abdomen and thorax\", section on 'Pneumonia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Empyema",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida empyema occurs most commonly in patients with malignancies, particularly as a nosocomial infection. Over one-quarter of patients with Candida empyema also has candidemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/40/18055?source=see_link&amp;anchor=H6#H6\">",
"     \"Candida infections of the abdomen and thorax\", section on 'Empyema'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Mediastinitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida mediastinitis almost always occurs after thoracic surgery procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42071/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. In a report of nine cases of Candida mediastinitis, the primary clinical manifestations included chest wall erythema",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    drainage, fever, and sternal instability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42071/abstract/11\">",
"     11",
"    </a>",
"    ]. These findings are similar to those seen with bacterial causes of postoperative mediastinitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/48/1800?source=see_link\">",
"     \"Postoperative mediastinitis after cardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Candida mediastinitis is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/40/18055?source=see_link&amp;anchor=H8#H8\">",
"     \"Candida infections of the abdomen and thorax\", section on 'Mediastinitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Pericarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Purulent pericarditis due to Candida species is rare, but life-threatening. It most often arises as a complication of thoracic surgery or contiguous spread from an adjacent focus, but hematogenous spread can occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42071/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. C. albicans is the most common pathogen, but infection with C. tropicalis and C. glabrata has also been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42071/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/40/18055?source=see_link&amp;anchor=H10#H10\">",
"     \"Candida infections of the abdomen and thorax\", section on 'Pericarditis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL TRACT COLONIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candida species are part of the normal flora of the gastrointestinal tract. Isolation of Candida species from stool cultures does not represent infection, and therefore does not warrant treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinical manifestations of infection with Candida species range from local mucous membrane infections to widespread dissemination with multisystem organ failure. Although Candida are considered normal flora in the gastrointestinal and genitourinary tracts of humans, they have the propensity to invade and cause disease when an imbalance is created in the ecologic niche in which these organisms usually exist. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Oropharyngeal candidiasis, or thrush, is a common local infection seen in infants; older adults who wear dentures; patients treated with antibiotics, chemotherapy, or radiation therapy to the head and neck; and those with cellular immune deficiency states, such as AIDS. Patients with xerostomia and those treated with inhaled glucocorticoids for asthma or rhinitis are also at risk. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Oropharyngeal candidiasis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Esophageal candidiasis is most common in HIV-infected patients, in which it is an AIDS-defining illness, and in patients with hematologic malignancies. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/17/29972?source=see_link\">",
"       \"Clinical manifestations of oropharyngeal and esophageal candidiasis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/38/4707?source=see_link\">",
"       \"Evaluation of the HIV-infected patient with odynophagia and dysphagia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vulvovaginal candidiasis is the most common form of mucosal candidiasis. It most often occurs in situations associated with increased estrogen levels, such as oral contraceptive use and pregnancy. Antibiotics, glucocorticoids, diabetes mellitus, HIV infection, intrauterine devices, and diaphragm use are also risk factors. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Vulvovaginitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic mucocutaneous candidiasis is a rare syndrome that usually has its onset in childhood. Some patients have autosomal recessive polyglandular autoimmune syndrome type I, which is also referred to as the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) syndrome. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Chronic mucocutaneous candidiasis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Candidemia refers to the presence of Candida species in the blood. Immunocompromised hosts and patients in intensive care units are at the highest risk of candidemia. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Risk factors for invasive infection'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Candidemia and invasive candidiasis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hepatosplenic candidiasis (also called chronic disseminated candidiasis) is seen almost entirely in patients with hematologic malignancies who have just recovered from an episode of neutropenia. Some patients have a documented prior episode of candidemia; in others, it is assumed that the patient was candidemic during the period of neutropenia. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Hepatosplenic or chronic disseminated candidiasis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Invasive focal infections include urinary tract infection, endophthalmitis, osteoarticular infections, meningitis, endocarditis, peritonitis and intraabdominal infections, empyema, mediastinitis, and pericarditis. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Invasive focal infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pneumonia due to Candida is extremely rare. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Pneumonia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/1\">",
"      Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/2\">",
"      Calandra T, Bille J, Schneider R, et al. Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989; 2:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/3\">",
"      Sandven P, Qvist H, Skovlund E, et al. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 2002; 30:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/4\">",
"      Grewe M, Tsiotos GG, Luque de-Leon E, Sarr MG. Fungal infection in acute necrotizing pancreatitis. J Am Coll Surg 1999; 188:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/5\">",
"      Hoerauf A, Hammer S, M&uuml;ller-Myhsok B, Rupprecht H. Intra-abdominal Candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality. Crit Care Med 1998; 26:2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/6\">",
"      Keiser P, Keay S. Candidal pancreatic abscesses: report of two cases and review. Clin Infect Dis 1992; 14:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/7\">",
"      Morris AB, Sands ML, Shiraki M, et al. Gallbladder and biliary tract candidiasis: nine cases and review. Rev Infect Dis 1990; 12:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/8\">",
"      Bozzette SA, Gordon RL, Yen A, et al. Biliary concentrations of fluconazole in a patient with candidal cholecystitis: case report. Clin Infect Dis 1992; 15:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/9\">",
"      Adamson PC, Rinaldi MG, Pizzo PA, Walsh TJ. Amphotericin B in the treatment of Candida cholecystitis. Pediatr Infect Dis J 1989; 8:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/10\">",
"      Berrouane YF, Herwaldt LA, Pfaller MA. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol 1999; 37:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/11\">",
"      Clancy CJ, Nguyen MH, Morris AJ. Candidal mediastinitis: an emerging clinical entity. Clin Infect Dis 1997; 25:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/12\">",
"      Malani PN, McNeil SA, Bradley SF, Kauffman CA. Candida albicans sternal wound infections: a chronic and recurrent complication of median sternotomy. Clin Infect Dis 2002; 35:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/13\">",
"      Glower DD, Douglas JM Jr, Gaynor JW, et al. Candida mediastinitis after a cardiac operation. Ann Thorac Surg 1990; 49:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/14\">",
"      Pertowski CA, Baron RC, Lasker BA, et al. Nosocomial outbreak of Candida albicans sternal wound infections following cardiac surgery traced to a scrub nurse. J Infect Dis 1995; 172:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/15\">",
"      Rabinovici R, Szewczyk D, Ovadia P, et al. Candida pericarditis: clinical profile and treatment. Ann Thorac Surg 1997; 63:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/16\">",
"      Schrank JH Jr, Dooley DP. Purulent pericarditis caused by Candida species: case report and review. Clin Infect Dis 1995; 21:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/17\">",
"      Neughebauer B, Alvarez V, Harb T, Keefer M. Constrictive pericarditis caused by candida glabrata in an immunocompetent patient: case report and review of literature. Scand J Infect Dis 2002; 34:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42071/abstract/18\">",
"      Chaudhary, K, Faidas, A, Baddour, LM. Candida pericarditis: unusual complication following hiatal hernia repair. Infect Dis Clin Pract 1996; 5:339.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2416 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-F7344C3B4D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42071=[""].join("\n");
var outline_f41_5_42071=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LOCAL MUCOCUTANEOUS INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Oropharyngeal candidiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Esophagitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Vulvovaginitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Balanitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Chronic mucocutaneous candidiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mastitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      RISK FACTORS FOR INVASIVE INFECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CANDIDEMIA AND INVASIVE CANDIDIASIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      HEPATOSPLENIC OR CHRONIC DISSEMINATED CANDIDIASIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      INVASIVE FOCAL INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Urinary tract infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Endophthalmitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Osteoarticular infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Meningitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Peritonitis and intraabdominal infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Pneumonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Empyema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Mediastinitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Pericarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      GASTROINTESTINAL TRACT COLONIZATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2416\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2416|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?26/63/27632\" title=\"diagnostic image 1\">",
"      Hepatosplenic candidiasis CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2416|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/12/5312\" title=\"picture 1\">",
"      Oropharyngeal candidiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?7/32/7680\" title=\"picture 2\">",
"      Candida denture stomatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/43/9919\" title=\"picture 3\">",
"      Candida esophagitis CPC Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/37/9809\" title=\"picture 4\">",
"      Candida albicans vaginitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?12/10/12463\" title=\"picture 5\">",
"      Balanoposthitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?10/1/10258\" title=\"picture 6\">",
"      Chronic mucocutaneous candidiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/63/34815\" title=\"picture 7\">",
"      Disseminated candidiasis skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/42/25248\" title=\"picture 8\">",
"      Disseminated candidiasis nodule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/21/35166\" title=\"picture 9\">",
"      Budding yeast Gram stain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/49/38672\" title=\"picture 10\">",
"      Disseminated candidiasis kidney",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/1/25630\" title=\"picture 11\">",
"      Candida endophthalmitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/39/25214\" title=\"picture 12\">",
"      Vitritis in endophthalmitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/20/4424?source=related_link\">",
"      Approach to the patient with chronic meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/33/14872?source=related_link\">",
"      Balanitis and balanoposthitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/19/37176?source=related_link\">",
"      Biology of Candida infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/39/40566?source=related_link\">",
"      Candida endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/40/18055?source=related_link\">",
"      Candida infections of the abdomen and thorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/49/15128?source=related_link\">",
"      Candida infections of the bladder and kidneys",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39559?source=related_link\">",
"      Candida infections of the central nervous system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/25/11671?source=related_link\">",
"      Candida osteoarticular infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=related_link\">",
"      Candida vulvovaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/0/40969?source=related_link\">",
"      Causes of primary adrenal insufficiency (Addison's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/1/22553?source=related_link\">",
"      Chronic mucocutaneous candidiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/6/36966?source=related_link\">",
"      Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/17/29972?source=related_link\">",
"      Clinical manifestations of oropharyngeal and esophageal candidiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/15/17658?source=related_link\">",
"      Common problems of breastfeeding and weaning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/24/41352?source=related_link\">",
"      Diagnostic approach to infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/48/37638?source=related_link\">",
"      Epidemiology and pathogenesis of candidemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/38/4707?source=related_link\">",
"      Evaluation of the HIV-infected patient with odynophagia and dysphagia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8631?source=related_link\">",
"      Fungal peritonitis in continuous peritoneal dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/53/10071?source=related_link\">",
"      Hepatosplenic candidiasis (chronic disseminated candidiasis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/48/1800?source=related_link\">",
"      Postoperative mediastinitis after cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29914?source=related_link\">",
"      Treatment of candidemia and invasive candidiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/12/39112?source=related_link\">",
"      Treatment of endogenous endophthalmitis due to Candida species",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/16/36102?source=related_link\">",
"      Treatment of exogenous endophthalmitis due to Candida species",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_5_42072="Overview of pancreatic stenting and its complications";
var content_f41_5_42072=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of pancreatic stenting and its complications",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42072/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42072/contributors\">",
"     Marc F Catalano, MD, FACP, FACG",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42072/contributors\">",
"     Vivek Kaul, MD, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42072/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42072/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42072/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42072/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/5/42072/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic endotherapy has been increasingly used for the treatment of a variety of pancreatic disorders including chronic pancreatitis, idiopathic acute recurrent pancreatitis, pancreatic duct leaks or disruptions, drainage of pseudocysts, and the prevention of pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP).",
"   </p>",
"   <p>",
"    One of the most common types of pancreatic endotherapy is pancreatic stenting. Stenting of the main pancreatic duct has been used to relieve ductal obstruction, often in the setting of refractory pain from strictures, stones, or papillary stenosis. In addition, stenting of the minor papilla has been used in the treatment of symptomatic pancreas divisum secondary to a stenotic minor papilla [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/1\">",
"     1",
"    </a>",
"    ]. The indications, efficacy and complications related to pancreatic stents will be reviewed here. The role of pancreatic stents to prevent ERCP-induced pancreatitis is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/28/22983?source=see_link\">",
"     \"Prophylactic pancreatic stents to prevent ERCP-induced pancreatitis: When do you use them?\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INSTRUMENTS AND TECHNIQUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of guidewires, dilators, and stents are available. The choice of instruments will depend upon the clinical setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Guidewires",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guidewires vary in diameter (0.018\", 0.021\", 0.025\", and 0.035\") and length, and may be hydrophilic, straight, have a \"J\" tip, or a loop tip. They are available with various radiopaque markings to minimize fluoroscopy time. Some guidewires are Teflon-coated, which provides the greatest stability for stent placement and accessory exchanges. Electrically insulated wires can be left in place during sphincterotomy. Glidewire and \"Roadrunner\" are special wires used for difficult cannulation and access at ERCP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Dilators",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two types of dilators are most commonly used: balloon dilators and dilating catheters. Balloon dilators are inflation devices housed on a catheter, which are used to deliver a specific pressure to a strictured or stenosed area. They are available in several diameters and lengths. An inflation device is required to pressurize the balloon at a controlled rate.",
"   </p>",
"   <p>",
"    Dilating catheters are available with a variety of tip sizes (3 French to 11.5 French) or as graduated dilating catheters. The French size of the tip of the catheter limits the size of the guidewire that can be used with it.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biliary and pancreatic stents are available in varying shapes, sizes, and numbers of",
"    <span class=\"nowrap\">",
"     barbs/flanges",
"    </span>",
"    or pigtails. Biliary stents can be temporary (eg, polyethylene, Teflon) or permanent (eg, Wallstents). Pancreatic stents are usually polyethylene, ranging from 3 to 10 French size with two to four total barbs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stent selection depends upon the size of the lumen and length to be traversed. The size and shape of the stent appear to have a bearing upon efficacy and safety when used for prevention of post-ERCP pancreatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/3\">",
"     3",
"    </a>",
"    ]. A retrospective study involving 479 patients who underwent pancreatic stenting found that small diameter (3 to 4 Fr), unflanged stents were significantly less likely to be associated with ductal changes compared with 5 to 6 mm stents (24 versus 80 percent). In addition, 3 or 4 Fr stents appeared to be more effective than 5 and 6 Fr stents in preventing post-ERCP pancreatitis (8 to 11 percent versus 11 to 17 percent). However, these smaller stents require additional wires and may be more difficult to place.",
"   </p>",
"   <p>",
"    Similar findings on ductal changes have been reported in other series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/4\">",
"     4",
"    </a>",
"    ]. However, other studies have shown no significant differences based on stent size alone. More studies are needed to define optimal stent size and length for specific indications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stent placement requires deep cannulation of the requisite duct followed by placement of a guidewire across the stricture or stone over which the stent is then advanced. Endoscopic sphincterotomy and stricture dilatation may be required but are not prerequisite.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for pancreatic duct stenting include pancreatic duct stones, pancreatic duct strictures, pseudocysts, pancreatic duct disruptions, pancreas divisum, pancreatic sphincterotomy, and the prevention of post-ERCP pancreatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pancreatic duct stones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic duct stones are found in 22 to 60 percent of patients with chronic pancreatitis (CP) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/6\">",
"     6",
"    </a>",
"    ]. The stones can lead to obstruction of outflow of pancreatic secretions, causing increased intraductal pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/7\">",
"     7",
"    </a>",
"    ]. Because the pancreas is relatively noncompliant, the rise in intraductal pressure can induce tissue hypertension and ischemia, which may be a major factor causing pain in patients with CP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/41/39575?source=see_link\">",
"     \"Etiology and pathogenesis of chronic pancreatitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pancreatic duct stenting may be beneficial as part of endoscopic therapy for pancreatic duct stones in the following settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Main pancreatic duct sphincterotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic duct sphincterotomy is the most critical part of pancreatic endotherapy, since it permits access to the main pancreatic duct, allowing various accessories to assist in stone removal. Pancreatic sphincterotomy can be performed with a sphincterotome over a guidewire or a needle-knife over a previously placed pancreatic stent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/10/25767?source=see_link\">",
"     \"Precut (access) papillotomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Facilitation of extra corporeal shock wave lithotripsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extracorporeal shock wave lithotripsy (ESWL) of pancreatic stones should be considered when endoscopic procedures fail to remove large or impacted stones. In the majority of patients, a radiologic target system is needed, which can be provided by the placement of a stent. Fluoroscopic focusing of densely calcified stones can be achieved without pancreatography. The European experience has proven that ESWL is a safe, novel therapy for treatment of pancreatic stones and this modality is also used at some centers in the United States. It is an effective adjunct to the nonsurgical endoscopic approach in chronic calcifying pancreatitis with complete or partial relief of symptoms in 80 percent of patients, which is comparable to the surgical literature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/59/10168?source=see_link\">",
"     \"Extracorporeal shock wave lithotripsy for pancreatic stones\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Stones associated with pancreatic duct strictures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary indication for endoscopic treatment of pancreatic duct strictures is the symptomatic relief of pain. In patients with stone formation proximal to a stricture, the combination of stent placement and ESWL or endotherapy facilitates removal of fragments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Incomplete stone extraction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stent placement assists in drainage of pancreatic juices and fragments if stone removal is incomplete. Symptomatic improvement in these patients has been observed after sphincterotomy with or without endoprosthesis placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Considering the above, endoscopic therapy should be considered as a first-line approach in the management of symptomatic main PD stones. Symptomatic improvement is most evident in patients with chronic relapsing pancreatitis. Factors that favor stone removal include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Three or fewer stones",
"     </li>",
"     <li>",
"      Stones confined to head",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      body of pancreas",
"     </li>",
"     <li>",
"      Stone size &lt;10 mm",
"     </li>",
"     <li>",
"      Absence of impacted stones",
"     </li>",
"     <li>",
"      Absence of downstream strictures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Multiple stones, large stones, or those associated with strictures require a combination of sphincterotomy, ESWL, stricture dilation,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    stent placement. Standard pancreatic stents are plastic with multiple side holes and flaps on both ends to assist anchorage. Stent size and length depend upon presence of ductal dilation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    strictures. After dilation, most ducts will accept 7 Fr stents. Stents can be left in place for 6 to 12 weeks prior to exchange, with the endpoint of therapy being symptom relief.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Pancreatic duct strictures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic duct strictures are common manifestations of chronic pancreatitis that may contribute to pain, recurrent acute pancreatitis, and exocrine insufficiency. Strictures may also be associated with stones, pseudocysts, and pancreatic malignancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/16-19\">",
"     16-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endoscopic therapy for pancreatic duct strictures is indicated primarily for patients presenting with refractory abdominal pain, with or without upstream ductal dilation. Polyethylene and Teflon stents ranging from 5 Fr to 10 Fr size have been used. The choice of stent is influenced by the strictures severity, its location, and the size of the pancreatic duct.",
"   </p>",
"   <p>",
"    The results of stent insertion for dominant pancreatic duct strictures has been favorable, with technical success in 72 to 100 percent, relief of pain in 75 to 94 percent, and good long-term outcomes in 52 to 74 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/20-23\">",
"     20-23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pseudocysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pseudocysts occur in and around the pancreas in patients with acute or chronic pancreatitis or ductal leakage due to other causes, such as trauma. As an example, pseudocysts develop in approximately 10 percent of patients with acute pancreatitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/32/17928?source=see_link\">",
"     \"Diagnosis and management of pseudocysts of the pancreas\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endoscopic drainage of the pseudocyst can be achieved by transmural cystenterostomy or transpapillary stent placement for pseudocysts that communicate with the main pancreatic duct. Pancreatic ductal obstruction caused by strictures or stones has to be relieved to prevent pseudocyst recurrence. Adequate drainage can be accomplished by placement of a stent in patients in whom obstruction is in the downstream (near papilla) portion of the main pancreatic duct. Transpapillary drainage occasionally requires biliary sphincterotomy, followed by pancreatic sphincterotomy and placement of a pancreatic stent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/0/27655?source=see_link\">",
"     \"Endoscopic management of pseudocysts of the pancreas: Technique\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/53/39766?source=see_link\">",
"     \"Endoscopic management of pseudocysts of the pancreas: Efficacy and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Pancreatic duct disruptions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ductal disruptions are common in persistent smoldering pancreatitis, pancreatic trauma, pancreatic necrosis, and in acute pancreatic fluid collections. Leakage of pancreatic secretions through these disruptions can result in the development of chronic fistulas, which can be internal or external. Closure of fistulas depends upon a number of factors including the site and size of duct disruption, whether there is superinfection downstream of the obstruction, whether the disruption is a consequence of a stricture or stone, and whether the ductal disruption is partial or complete.",
"   </p>",
"   <p>",
"    Findings on ERCP suggestive of a duct disruption include extravasation of contrast during injection of the pancreatic duct, the presence of fluid collections or pseudocysts that communicate directly with the main pancreatic duct, pancreatic ascites, or the presence of a pancreatic fistula [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transpapillary stenting in conjunction with continued medical therapy has been successful in a number of settings including refractory pancreaticocutaneous fistulas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/25\">",
"     25",
"    </a>",
"    ], pancreatic ascites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/26,27\">",
"     26,27",
"    </a>",
"    ], pancreatic pleural effusions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/28\">",
"     28",
"    </a>",
"    ], and pancreatic-enteric fistulas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/29\">",
"     29",
"    </a>",
"    ]. Resolution of fluid collections and patient symptoms determine efficacy. Stents are usually retrieved after four to six weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Pancreas divisum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic endoscopy in patients with pancreas divisum continues to evolve with the availability of minor papilla endoscopic sphincterotomy, stenting, or sphincteroplasty (balloon or catheter dilation) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/30-33\">",
"     30-33",
"    </a>",
"    ]. Stenting of the minor papilla has been used both diagnostically (in which a stent is placed to determine if ductal obstruction is the cause of pancreatitis or pain) and therapeutically. Short-term stenting for diagnostic purposes is of uncertain benefit, particularly in patients with infrequent episodes of pain (one or two times a year). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/58/15271?source=see_link\">",
"     \"Treatment of pancreas divisum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, the benefit of stenting is more apparent after long-term follow-up and in patients with frequent pain or pancreatitis episodes. This was illustrated in a prospective trial in which 19 patients with pancreas divisum and at least two episodes of pancreatitis who randomized to dorsal duct stent placement or observation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/31\">",
"     31",
"    </a>",
"    ]. The stents (3 to 7 cm long with multiple side-holes) were exchanged every three to four months and were left in place for one year. The stented patients had a much higher rate of improvement (90 versus 11 percent) due to statistically significantly reductions in hospitalization, emergency department visits, and episodes of pancreatitis. These benefits generally persisted over a mean 24-month follow-up period after stent removal. Similar conclusions have been reached in other uncontrolled studies.",
"   </p>",
"   <p>",
"    Despite these encouraging results, stenting in pancreas divisum should be practiced judiciously after careful risk-benefit evaluation due to potentially worrisome ductal and periductal changes induced by stents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Stent-related ductal changes'",
"    </a>",
"    below.) This topic is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/58/15271?source=see_link\">",
"     \"Treatment of pancreas divisum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Recurrent idiopathic acute pancreatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;No obvious etiology is identifiable in approximately 30 percent of patients with acute pancreatitis. The role of pancreatic stenting in this setting has not been well studied. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/61/14297?source=see_link\">",
"     \"Etiology of acute pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pancreatic sphincterotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic pancreatic sphincterotomy of the major and minor papilla has changed the approach to management of a variety of pancreatic disorders. However, in most reports, a higher rate of complications has been observed with pancreatic sphincterotomy when compared with biliary sphincterotomy primarily due to an increased incidence of pancreatitis. The risk may be greatest in patients with pancreatic sphincter hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It has been hypothesized that achievement of adequate pancreatic drainage (either with a stent or a nasopancreatic catheter) could reduce the incidence of pancreatitis following pancreatic sphincterotomy. This hypothesis has been confirmed in a number of reports.",
"   </p>",
"   <p>",
"    The role of pancreatic stenting to prevent post-ERCP pancreatitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/28/22983?source=see_link\">",
"     \"Prophylactic pancreatic stents to prevent ERCP-induced pancreatitis: When do you use them?\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is an inherent risk of complications with any endoscopic therapy, but pancreatic endotherapy in particular can result in substantial risk. The problems associated with pancreatic stenting can be broadly divided into early and late complications. The principal early complications include acute pancreatitis and pain, and much less commonly, perforation and cholangitis. Rare fatalities have been reported from sepsis and pancreatitis. Late complications include pancreatic ductal and parenchymal changes that resemble chronic pancreatitis, and stent malfunction, which is principally due to occlusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Early complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spectrum and frequency of early complications can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immediate complications (including pancreatitis, pain, and ductal rupture from bougie esophageal dilation) were observed in 24 percent of 21 patients in one study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/37\">",
"       37",
"      </a>",
"      ]. Pancreatitis appears to be more likely after a failed attempt at pancreatic stent insertion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Early complications (including bleeding, pancreatitis, and a guidewire fracture requiring surgical removal of the broken fragment) developed in 18 percent of 51 patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A higher rate of acute pancreatitis (39 percent) was noted in a series of 23 patients after initial placement or exchange of stents [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Acute cholangitis is another complication of stent placement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/22,37\">",
"       22,37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Late complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most concerning long-term complication related to pancreatic stents is the development of pancreatic ductal and sometimes parenchymal changes that resemble chronic pancreatitis. Other late complications are primarily related to stent occlusion, migration, and clogging, which occur in more than one-half of patients, and can usually be addressed endoscopically [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Stent-related ductal changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, pancreatic stents may induce morphologic changes that resemble chronic pancreatitis (dilation of side branches, narrowing, and ductal irregularities) and may require therapeutic intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/39\">",
"     39",
"    </a>",
"    ]. In a canine model, associated pathologic changes included inflammation, fibrosis, and parenchymal atrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/34\">",
"     34",
"    </a>",
"    ]. In humans, the vast majority of parenchymal changes seem to be associated with the proximal end of the stent, which causes an inflammatory response with edema and ductal narrowing (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62772 graphicRef63364 graphicRef59903 graphicRef70294 \" href=\"mobipreview.htm?35/13/36055\">",
"     image 1A-D",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The risk of pancreatic duct changes can be illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one series, ductal changes were observed in 36 percent of 34 patients, 72 percent of whom had previously normal ductograms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/40\">",
"       40",
"      </a>",
"      ]. Most of these changes were attributed to stent occlusion and resolved with stent change or removal.",
"     </li>",
"     <li>",
"      In a second report focusing on 25 patients with chronic pancreatitis, stent-induced strictures were observed in 18 percent of 40 stent episodes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A third study of 61 patients demonstrated stent-induced changes in 80 percent, including ductal irregularity in 49 percent, narrowing in 26 percent, and side branch changes in 16 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/42\">",
"       42",
"      </a>",
"      ]. These changes occurred with equal frequency in those with normal and abnormal baseline pancreatograms and were independent of stent size, length, patency, duration of placement, and baseline pancreatogram findings. More than one-third of these changes persisted during a mean follow-up period of approximately six months after stent removal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data clearly demonstrate that the potential benefit of stenting should be weighed carefully against the risk of complications. As noted above, the risk of stent-related ductal changes may be reduced by use of small (3 to 4 Fr) unflanged stents for shorter periods, when possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Stent occlusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occlusion rates of pancreatic stents parallel those described for biliary stents of the same caliber. Most stents occlude in two to four months. In one series, for example, 50 percent of the stents occluded by six weeks and all stents occluded by nine weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/43\">",
"     43",
"    </a>",
"    ]. Similar to biliary stents, larger caliber pancreatic stents have longer patency rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/20\">",
"     20",
"    </a>",
"    ]. One series, for example, observed only a 13 percent occlusion rate at two months when a 10 Fr stent was used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/20\">",
"     20",
"    </a>",
"    ]. In addition, larger side holes may also decrease the rate of occlusion. A study of 68 patients found that stents with larger side holes were 54 percent less likely to be occluded at the time of removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The adherence of proteins to the inner surface of the stent seems to play a central role in stent occlusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/42\">",
"     42",
"    </a>",
"    ]. The occluding material often consists of a protein matrix laden with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/32/42504?source=see_link\">",
"     calcium carbonate",
"    </a>",
"    crystals, bacteria, and necrotic cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The development of occlusion may be associated with pain or acute pancreatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/21,43,46\">",
"     21,43,46",
"    </a>",
"    ]. As a result, most authorities recommend that pancreatic stents should be exchanged electively at predetermined intervals. However, the issue of when to exchange a stent has not been settled. Issues surrounding this uncertainty are the variable rate with which patients with clogged stents develop recurrent symptoms and the risk, cost, and inconvenience associated with ERCP. In one series, only 6 percent of patients with clogged stents developed pancreatitis or pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/43\">",
"     43",
"    </a>",
"    ]. The low incidence of symptoms despite a high rate of stent occlusion suggests that the stent may function as a \"wick\" around which pancreatic juices continue to drain. Nevertheless, we recommend stent replacement every six to eight weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Stent migration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Distal migration (outside the duct) rarely presents a problem, but upstream migration (into the duct) may be more serious given the morphological changes in the pancreatic duct that can be induced by a stent and the technical challenges associated with attempts at retrieval. In one report, proximal and distal migration developed in 5.2 and 7.5 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/46\">",
"     46",
"    </a>",
"    ]. Proximal migration was more likely in patients with sphincter of Oddi dysfunction and in those who were treated with longer stents. Case reports have demonstrated intra-pancreatic embedding of a pancreatic stent requiring surgical removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/47\">",
"     47",
"    </a>",
"    ] and the development of bile duct-duodenal and pancreatic-gastric fistulas as a result of stenting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    More than 80 percent of migrated pancreatic stents can be retrieved endoscopically (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58513 \" href=\"mobipreview.htm?19/13/19679\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/49\">",
"     49",
"    </a>",
"    ]. Surgery should be considered in symptomatic patients with proximally migrated dorsal or main pancreatic duct stents in whom repeated ERCP retrieval attempts have failed. Direct single operator pancreatoscopy (Spyglass system, Boston Scientific) may facilitate removal of migrated pancreatic stents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications related to pancreatic duct stents are often found incidentally following stent removal and final pancreatography. Thus, it is important to obtain an adequate pancreatogram following stent removal, particularly if further stent placement is contemplated.",
"   </p>",
"   <p>",
"    Complications can also involve the pancreatic parenchyma immediately surrounding the stented portion of the pancreatic duct, which may be visible during endoscopic ultrasound (EUS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/50\">",
"     50",
"    </a>",
"    ]. It has been suggested that EUS may be used as a screening study to detect the earliest changes of chronic pancreatitis from stenting with a high degree of sensitivity. We perform pre-ERCP",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/49/28435?source=see_link\">",
"     secretin",
"    </a>",
"    stimulated EUS during evaluation of patients with chronic pancreatitis. However, lack of a true gold standard for the diagnosis of early chronic pancreatitis does not permit absolute confirmation of specific EUS ductal and parenchymal features.",
"   </p>",
"   <p>",
"    Acute complications from pancreatic duct stenting such as acute pancreatitis and pancreatic pseudocysts can be detected by noninvasive imaging, such as transabdominal ultrasound",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    computed tomography, and laboratory studies including serum amylase and lipase.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are multiple ways to decrease the risk of complications associated with pancreatic duct stenting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Indications and endoscopist experience",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is imperative that pancreatic duct stenting be chosen for the appropriate indication and that an experienced endoscopist perform the procedure. Patients with marginal or evolving indications should be treated under strict protocols and after careful discussion of risks, benefits, and complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Stent choice and replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of stent migration can be decreased by avoiding stents that extend beyond the genu of the pancreas. In addition, modifications of stent designs have been attempted to reduce the risk of migration. One possible approach is eliminating the two internal barbs, which in one report, decreased internal migration but increased outward migration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/51\">",
"     51",
"    </a>",
"    ]. As noted above, the risk of stent-related ductal changes may be reduced by use of small (3 to 4 Fr) unflanged stents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While not all patients whose stents become occluded develop symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/43\">",
"     43",
"    </a>",
"    ], it is not possible to predict which patients are at risk. Thus, we suggest that stents be replaced every six to eight weeks since nearly 100 percent will be occluded by three months. Patients requiring repeated stent exchanges benefit from using varying stent lengths at subsequent visits, since the majority of stent-induced ductal changes occur at the proximal end of the stent within the pancreatic duct. Whenever possible, short stents are preferred over longer stents to limit the extent of duct in contact with foreign material.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Nasopancreatic stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Placement of a nasopancreatic stent may be an alternative to pancreatic stenting. In two reports of 375 consecutive cases undergoing pancreatic sphincterotomy with drainage, a 5 Fr nasopancreatic drain was left overnight with pre-discharge removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. There was only a single case of mild post-ERCP pancreatitis upon nasopancreatic drain removal, 12 to 24 hours following placement. Advantages compared with pancreatic stenting include: eliminating the possibility of stent migration, potential for cost savings by avoiding the need for a repeat endoscopy to remove the 20 to 30 percent of pancreatic stents that fail to pass on their own, reducing the risk of stent related complications in non-compliant patients who fail to follow-up. Drawbacks include greater technical difficulty with placement and patient discomfort with nasal positioning and removal. Additional studies are needed to evaluate the role of nasopancreatic catheter drainage in pancreatic endotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Pancreatic stenting technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proper stent placement and removal techniques can minimize the inherent risk associated with pancreatic stenting and should be emphasized in training and followed in practice. A full review is beyond the scope of this topic review, but a few points need to be highlighted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There should be a strong indication for prophylactic stenting. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/28/22983?source=see_link\">",
"       \"Prophylactic pancreatic stents to prevent ERCP-induced pancreatitis: When do you use them?\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The pancreatic duct anatomy should dictate further attempts at stent placement and the choice of stent. As an example, a difficult ansa loop may prevent deep wire cannulation, suggesting that a shorter transpapillary stent may be preferable [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42072/abstract/38\">",
"       38",
"      </a>",
"      ]. However, any stent will be difficult to place if there is not enough intraductal wire to \"pull in\" the stent, a point that has to be factored into the decision-making process.",
"     </li>",
"     <li>",
"      Stents should be either long enough to be clearly upstream of the genu or short enough to be just transpapillary. Stents with the upstream portion at the genu may be more traumatic and cause increased ductal injury.",
"     </li>",
"     <li>",
"      Careful attention should be paid while placing the stent to ensure the stent is not inadvertently placed completely within the pancreatic duct due to increased wire traction by the assistant or an increased force on the pushing catheter by the endoscopist. Proper and final placement should be photo documented.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Proper pancreatic stent removal techniques also need to be considered. Stent fracture",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    intrapancreatic upstream migration while attempting removal can have serious consequences. It is important to grasp the stent close to the tip, distal to the flaps. Excessive tightening of the snare around the stent should be avoided.",
"   </p>",
"   <p>",
"    Similarly, excessive pulling force by the endoscopist is not recommended. It is preferable to use the mechanical forces of the duodenoscope and proper extraction maneuvers to remove the stent (grasp snare with left hand at accessory channel, shorten endoscope with",
"    <span class=\"nowrap\">",
"     up/down",
"    </span>",
"    control and advance endoscope with clockwise torque).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stenting of the main pancreatic duct has been used to relieve ductal obstruction, often in the setting of refractory pain from strictures, stones, or papillary stenosis. However, its role in some of these settings is unclear, particularly since it can cause complications. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients undergoing endoscopic therapy for pancreatic duct stones, we suggest pancreatic stenting if pancreatic sphincterotomy is performed, if endoscopic shock wave lithotripsy is planned, if there are associated strictures, or if there is incomplete stone extraction (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pancreatic duct stones'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients undergoing endoscopic therapy for pancreatic duct strictures, we suggest pancreatic stenting (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Pancreatic duct strictures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The role of pancreatic stents for treatment of pseudocysts is described separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/0/27655?source=see_link\">",
"       \"Endoscopic management of pseudocysts of the pancreas: Technique\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/53/39766?source=see_link\">",
"       \"Endoscopic management of pseudocysts of the pancreas: Efficacy and complications\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/28/22983?source=see_link\">",
"       \"Prophylactic pancreatic stents to prevent ERCP-induced pancreatitis: When do you use them?\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The potential role of stenting in patients with pancreas divisum is still evolving, although it appears beneficial in patients with recurrent pancreatitis episodes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/58/15271?source=see_link\">",
"       \"Treatment of pancreas divisum\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with recurrent, idiopathic acute pancreatitis, the role of pancreatic stenting is unproven. We suggest they NOT be used routinely (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Recurrent idiopathic acute pancreatitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prophylactic pancreatic duct stenting to reduce the severity of post-ERCP pancreatitis in high-risk patients is being increasingly used. The role of stenting to prevent post-ERCP pancreatitis is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/28/22983?source=see_link\">",
"       \"Prophylactic pancreatic stents to prevent ERCP-induced pancreatitis: When do you use them?\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Complications associated with pancreatic stenting can be broadly divided into early and late. Early complications include stent migration, acute pancreatitis and pain, and much less commonly perforation and infection. Late complications include pancreatic ductal and parenchymal changes that resemble chronic pancreatitis, and stent migration and malfunction, which are principally due to occlusion. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/1\">",
"      Elta GH. Temporary prophylactic pancreatic stents: which patients need them? Gastrointest Endosc 2008; 67:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/2\">",
"      Somogyi L, Chuttani R, Croffie J, et al. Biliary and pancreatic stents. Gastrointest Endosc 2006; 63:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/3\">",
"      Rashdan A, Fogel EL, McHenry L Jr, et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004; 2:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/4\">",
"      Lawrence C, Cotton PB, Romagnuolo J, et al. Small prophylactic pancreatic duct stents: an assessment of spontaneous passage and stent-induced ductal abnormalities. Endoscopy 2007; 39:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/5\">",
"      Abdel Aziz, AM, Mchenry L, Fogel EL, et al. 3 Fr prophylactic pancreatic stent: What is the optimal stent length?. Gastrointest Endosc 2008; 67:AB326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/6\">",
"      Drake DH, Fry WJ. Ductal drainage for chronic pancreatitis. Surgery 1989; 105:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/7\">",
"      Bradley EL 3rd. Pancreatic duct pressure in chronic pancreatitis. Am J Surg 1982; 144:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/8\">",
"      Dumonceau JM, Devi&egrave;re J, Le Moine O, et al. Endoscopic pancreatic drainage in chronic pancreatitis associated with ductal stones: long-term results. Gastrointest Endosc 1996; 43:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/9\">",
"      Karanjia ND, Singh SM, Widdison AL, et al. Pancreatic ductal and interstitial pressures in cats with chronic pancreatitis. Dig Dis Sci 1992; 37:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/10\">",
"      Laugier R. Dynamic endoscopic manometry of the response to secretin in patients with chronic pancreatitis. Endoscopy 1994; 26:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/11\">",
"      Devi&egrave;re J, Delhaye M, Cremer M. Pancreatic duct stones management. Gastrointest Endosc Clin N Am 1998; 8:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/12\">",
"      Delhaye M, Vandermeeren A, Baize M, Cremer M. Extracorporeal shock-wave lithotripsy of pancreatic calculi. Gastroenterology 1992; 102:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/13\">",
"      Sauerbruch T, Holl J, Sackmann M, Paumgartner G. Extracorporeal lithotripsy of pancreatic stones in patients with chronic pancreatitis and pain: a prospective follow up study. Gut 1992; 33:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/14\">",
"      Sherman S, Lehman GA, Hawes RH, et al. Pancreatic ductal stones: frequency of successful endoscopic removal and improvement in symptoms. Gastrointest Endosc 1991; 37:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/15\">",
"      Huibregtse K, Schneider B, Vrij AA, Tytgat GN. Endoscopic pancreatic drainage in chronic pancreatitis. Gastrointest Endosc 1988; 34:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/16\">",
"      Nealon WH, Townsend CM Jr, Thompson JC. Operative drainage of the pancreatic duct delays functional impairment in patients with chronic pancreatitis. A prospective analysis. Ann Surg 1988; 208:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/17\">",
"      Smits ME, Rauws EA, Tytgat GN, Huibregtse K. Endoscopic treatment of pancreatic stones in patients with chronic pancreatitis. Gastrointest Endosc 1996; 43:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/18\">",
"      Barthet M, Sahel J, Bodiou-Bertei C, Bernard JP. Endoscopic transpapillary drainage of pancreatic pseudocysts. Gastrointest Endosc 1995; 42:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/19\">",
"      Catalano MF, Geenen JE, Schmalz MJ, et al. Treatment of pancreatic pseudocysts with ductal communication by transpapillary pancreatic duct endoprosthesis. Gastrointest Endosc 1995; 42:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/20\">",
"      Ponchon T, Bory RM, Hedelius F, et al. Endoscopic stenting for pain relief in chronic pancreatitis: results of a standardized protocol. Gastrointest Endosc 1995; 42:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/21\">",
"      Smits ME, Badiga SM, Rauws EA, et al. Long-term results of pancreatic stents in chronic pancreatitis. Gastrointest Endosc 1995; 42:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/22\">",
"      Cremer M, Devi&egrave;re J, Delhaye M, et al. Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy-six patients. Endoscopy 1991; 23:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/23\">",
"      Binmoeller KF, Jue P, Seifert H, et al. Endoscopic pancreatic stent drainage in chronic pancreatitis and a dominant stricture: long-term results. Endoscopy 1995; 27:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/24\">",
"      Devi&egrave;re J, Bueso H, Baize M, et al. Complete disruption of the main pancreatic duct: endoscopic management. Gastrointest Endosc 1995; 42:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/25\">",
"      Kozarek RA, Ball TJ, Patterson DJ, et al. Transpapillary stenting for pancreaticocutaneous fistulas. J Gastrointest Surg 1997; 1:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/26\">",
"      Kozarek RA, Jiranek GC, Traverso LW. Endoscopic treatment of pancreatic ascites. Am J Surg 1994; 168:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/27\">",
"      Bracher GA, Manocha AP, DeBanto JR, et al. Endoscopic pancreatic duct stenting to treat pancreatic ascites. Gastrointest Endosc 1999; 49:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/28\">",
"      Kozarek RA, Traverso LW. Endoscopic treatment of chronic pancreatitis: An alternative to surgery?. Dig Surg 1996; 13:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/29\">",
"      Wolfsen HC, Kozarek RA, Ball TJ, et al. Pancreaticoenteric fistula: no longer a surgical disease? J Clin Gastroenterol 1992; 14:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/30\">",
"      Catalano MF, Lahoti S, Alcocer E, et al. Dynamic imaging of the pancreas using real-time endoscopic ultrasonography with secretin stimulation. Gastrointest Endosc 1998; 48:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/31\">",
"      Lans JI, Geenen JE, Johanson JF, Hogan WJ. Endoscopic therapy in patients with pancreas divisum and acute pancreatitis: a prospective, randomized, controlled clinical trial. Gastrointest Endosc 1992; 38:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/32\">",
"      Ertan A. Long-term results after endoscopic pancreatic stent placement without pancreatic papillotomy in acute recurrent pancreatitis due to pancreas divisum. Gastrointest Endosc 2000; 52:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/33\">",
"      Heyries L, Barthet M, Delvasto C, et al. Long-term results of endoscopic management of pancreas divisum with recurrent acute pancreatitis. Gastrointest Endosc 2002; 55:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/34\">",
"      Sherman S, Alvarez C, Robert M, et al. Polyethylene pancreatic duct stent-induced changes in the normal dog pancreas. Gastrointest Endosc 1993; 39:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/35\">",
"      Tarnasky P, Cunningham J, Cotton P, et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 1997; 29:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/36\">",
"      Geenen JE, Rolny P. Endoscopic therapy of acute and chronic pancreatitis. Gastrointest Endosc 1991; 37:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/37\">",
"      Ashby K, Lo SK. The role of pancreatic stenting in obstructive ductal disorders other than pancreas divisum. Gastrointest Endosc 1995; 42:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/38\">",
"      Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004; 59:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/39\">",
"      Bakman YG, Safdar K, Freeman ML. Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy 2009; 41:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/40\">",
"      Kozarek RA. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc 1990; 36:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/41\">",
"      Morgan DE, Smith JK, Hawkins K, Wilcox CM. Endoscopic stent therapy in advanced chronic pancreatitis: relationships between ductal changes, clinical response, and stent patency. Am J Gastroenterol 2003; 98:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/42\">",
"      Smith MT, Sherman S, Ikenberry SO, et al. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 1996; 44:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/43\">",
"      Ikenberry SO, Sherman S, Hawes RH, et al. The occlusion rate of pancreatic stents. Gastrointest Endosc 1994; 40:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/44\">",
"      Buscaglia JM, DiMaio CJ, Pollack MJ, et al. Are large side holes associated with reduced rates of pancreatic stent occlusion? Results of a prospective study. JOP 2009; 10:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/45\">",
"      Provansal-Cheylan M, Bernard JP, Mariani A, et al. Occluded pancreatic endoprostheses--analysis of the clogging material. Endoscopy 1989; 21:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/46\">",
"      Johanson JF, Schmalz MJ, Geenen JE. Incidence and risk factors for biliary and pancreatic stent migration. Gastrointest Endosc 1992; 38:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/47\">",
"      Shapiro AM, Scudamore CH, July LV, et al. Calcific intra-pancreatic embedding of a pancreatic stent necessitating surgical removal--a danger of chronic endoscopic retrograde pancreatic stent placement. Gastrointest Endosc 1999; 50:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/48\">",
"      Heyries L, Desjeux A, Sahel J. Bile duct-duodenum and pancreatic-gastric fistulas: two exceptional complications of biliary and pancreatic stenting. Gastrointest Endosc 1999; 50:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/49\">",
"      Lahoti S, Catalano MF, Geenen JE, Schmalz MJ. Endoscopic retrieval of proximally migrated biliary and pancreatic stents: experience of a large referral center. Gastrointest Endosc 1998; 47:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/50\">",
"      Sherman S, Hawes RH, Savides TJ, et al. Stent-induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP. Gastrointest Endosc 1996; 44:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/51\">",
"      Johanson JF, Schmalz MJ, Geenen JE. Simple modification of a pancreatic duct stent to prevent proximal migration. Gastrointest Endosc 1993; 39:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/52\">",
"      Howell D, Bernadino K, Ansari A, et al. Refined technique of pancreatic duct endoscopic sphincterotomy (PDES) produces results comparable to biliary sphincterotomy: an eight year cohort study. Gastrointest Endosc 2005; 61:AB191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42072/abstract/53\">",
"      Elton E, Howell DA, Parsons WG, et al. Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique. Gastrointest Endosc 1998; 47:240.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2658 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.131.240.2-0CE6B713CC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42072=[""].join("\n");
var outline_f41_5_42072=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INSTRUMENTS AND TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Guidewires",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Dilators",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Stents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pancreatic duct stones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Main pancreatic duct sphincterotomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Facilitation of extra corporeal shock wave lithotripsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Stones associated with pancreatic duct strictures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Incomplete stone extraction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Pancreatic duct strictures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pseudocysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Pancreatic duct disruptions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Pancreas divisum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Recurrent idiopathic acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pancreatic sphincterotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Early complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Late complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Stent-related ductal changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Stent occlusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Stent migration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Indications and endoscopist experience",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Stent choice and replacement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Nasopancreatic stents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Pancreatic stenting technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2658\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2658|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?12/60/13263\" title=\"diagnostic image 1A\">",
"      Main pancreatic duct stricture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?24/30/25071\" title=\"diagnostic image 1B\">",
"      Parenchymal changes EUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?1/62/2031\" title=\"diagnostic image 1C\">",
"      Balloon dilation PD stricture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?18/35/19007\" title=\"diagnostic image 1D\">",
"      Follow up pancreatogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?19/13/19679\" title=\"diagnostic image 2\">",
"      Pancreatic stent migration",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/32/17928?source=related_link\">",
"      Diagnosis and management of pseudocysts of the pancreas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/53/39766?source=related_link\">",
"      Endoscopic management of pseudocysts of the pancreas: Efficacy and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/0/27655?source=related_link\">",
"      Endoscopic management of pseudocysts of the pancreas: Technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/41/39575?source=related_link\">",
"      Etiology and pathogenesis of chronic pancreatitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/61/14297?source=related_link\">",
"      Etiology of acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/59/10168?source=related_link\">",
"      Extracorporeal shock wave lithotripsy for pancreatic stones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/10/25767?source=related_link\">",
"      Precut (access) papillotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/28/22983?source=related_link\">",
"      Prophylactic pancreatic stents to prevent ERCP-induced pancreatitis: When do you use them?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/58/15271?source=related_link\">",
"      Treatment of pancreas divisum",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_5_42073="Cutaneous manifestations of graft-versus-host disease (GVHD)";
var content_f41_5_42073=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cutaneous manifestations of graft-versus-host disease (GVHD)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42073/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42073/contributors\">",
"     Edward W Cowen, MD, MHSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42073/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42073/contributors\">",
"     Jeffrey Callen, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/5/42073/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/5/42073/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/5/42073/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H3496485\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute and chronic graft-verus-host disease (GVHD) are multisystem disorders that are common complications of hematopoietic cell transplant (HCT). Skin involvement is common, and mucosal, hair, or nail abnormalities may also occur. Because these disorders share clinical and histopathological features with a variety of other skin diseases, thorough consideration of the differential diagnosis is essential for the management of post-HCT patients with lesions suggestive of cutaneous GVHD.",
"   </p>",
"   <p>",
"    The clinical and histopathological features, differential diagnosis, and supportive therapy of cutaneous GVHD will be reviewed here. The epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prevention of acute and chronic GVHD are reviewed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/24/18826?source=see_link\">",
"     \"Pathogenesis of graft-versus-host disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/22/25960?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10425?source=see_link\">",
"     \"Prevention and treatment of acute graft-versus-host disease: Recommendations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35385?source=see_link\">",
"     \"Treatment of chronic graft-versus-host disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2692898\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classically, GVHD has been divided into acute and chronic forms based upon the time of onset of disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute GVHD &ndash; Manifestations of GVHD occurring within 100 days after HCT",
"     </li>",
"     <li>",
"      Chronic GVHD &ndash; Manifestations of GVHD occurring more than 100 days after HCT",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, this conventional division has been challenged by the recognition that signs of acute and chronic GVHD may occur outside of these designated periods. This observation has led to increasing use of clinical findings, rather than a set time period, to differentiate between acute and chronic GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/22/25960?source=see_link&amp;anchor=H1#H1\">",
"     \"Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18902803\">",
"    <span class=\"h1\">",
"     ACUTE CUTANEOUS GVHD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute GVHD is common after allogenic hematopoietic cell transplant (HCT), and can lead to disorders of the skin, gastrointestinal tract, liver, and hematopoietic system. Cutaneous involvement is often the earliest manifestation of acute GVHD; skin lesions frequently appear within two to four weeks of HCT, but may occur anytime after hematopoietic cell engraftment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/22/25960?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18902811\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H878137\">",
"    <span class=\"h3\">",
"     Skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute cutaneous GVHD typically begins with erythematous, blanchable macules on the ears, palms, or soles (",
"    <a class=\"graphic graphic_picture graphicRef72825 \" href=\"mobipreview.htm?26/30/27107\">",
"     picture 1",
"    </a>",
"    ). The lateral neck, cheek, and upper back are additional common sites of early involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Follicularly based lesions are present in some patients (",
"    <a class=\"graphic graphic_picture graphicRef59686 \" href=\"mobipreview.htm?6/7/6258\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As acute cutaneous GVHD progresses, lesions become generalized, and the eruption often takes on a morbilliform (measles-like) appearance. Smooth or hyperkeratotic papules and postinflammatory hyperpigmentation may occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. In severe cases, patients develop generalized erythroderma, bullae, or extensive skin sloughing (",
"    <a class=\"graphic graphic_picture graphicRef66097 \" href=\"mobipreview.htm?0/41/659\">",
"     picture 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10425?source=see_link&amp;anchor=H3#H3\">",
"     \"Prevention and treatment of acute graft-versus-host disease: Recommendations\", section on 'Prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with acute cutaneous GVHD may complain of pruritus or a burning sensation in the skin. In some patients, skin pain or pruritus precedes the onset of visible skin lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with intestinal and hepatic GVHD, a staging system is used to describe the extent of cutaneous involvement (",
"    <a class=\"graphic graphic_table graphicRef68233 \" href=\"mobipreview.htm?8/63/9212\">",
"     table 1A",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Stage 1 &ndash;",
"      </strong>",
"      less than 25 percent body surface area (BSA) involvement",
"     </li>",
"     <li>",
"      <strong>",
"       Stage 2 &ndash;",
"      </strong>",
"      25 to 50 percent BSA involvement",
"     </li>",
"     <li>",
"      <strong>",
"       Stage 3 &ndash;",
"      </strong>",
"      greater than 50 percent BSA involvement",
"     </li>",
"     <li>",
"      <strong>",
"       Stage 4 &ndash;",
"      </strong>",
"      erythroderma with bullae",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The combined stages of skin, liver, and gastrointestinal disease are used to determine the overall severity (grade) of acute GVHD (",
"    <a class=\"graphic graphic_table graphicRef68233 graphicRef82692 \" href=\"mobipreview.htm?35/17/36125\">",
"     table 1A-B",
"    </a>",
"    ). The presence of erythroderma and bullae is sufficient to diagnose grade 4 GVHD, and is associated with a poor prognosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10425?source=see_link&amp;anchor=H2#H2\">",
"     \"Prevention and treatment of acute graft-versus-host disease: Recommendations\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H733754\">",
"    <span class=\"h3\">",
"     Oral lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythema, erosions, ulcers, lichenoid lesions, xerostomia, and pain involving the oral cavity have been attributed to acute GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. However, relatively little is known about oral acute GVHD due to difficulty in distinguishing this disorder from mucositis secondary to chemotherapy administered in preparation for HCT. Some authors have suggested that lesions that persist for longer than three weeks after HCT or involve the hard palate (an uncommon site for chemotherapy-induced mucositis) may be more likely to represent acute GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/22/38250?source=see_link\">",
"     \"Oral toxicity associated with chemotherapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18902827\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of concomitant extracutaneous manifestations, making a definitive diagnosis of acute cutaneous GVHD may be challenging. The clinical findings are nonspecific and can be difficult to distinguish clinically from other skin eruptions that occur in post-HCT patients and there are no pathognomonic histopathological features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/8\">",
"     8",
"    </a>",
"    ]. Correlation between clinical and pathologic findings is essential. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/22/25960?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H832193\">",
"    <span class=\"h3\">",
"     Skin biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 4 mm punch biopsy sent for hematoxylin and eosin staining is generally sufficient to evaluate for acute cutaneous GVHD. Immunofluorescence testing may demonstrate nonspecific IgM and complement deposits at the basement membrane zone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/9\">",
"     9",
"    </a>",
"    ], but generally is not indicated.",
"   </p>",
"   <p>",
"    Key histopathological findings in acute cutaneous GVHD include interface dermatitis (vacuolization of the basal layer of the epidermis and a lymphocytic infiltrate in the superficial dermis) and epidermal apoptotic keratinocytes (",
"    <a class=\"graphic graphic_picture graphicRef61055 \" href=\"mobipreview.htm?37/37/38487\">",
"     picture 4",
"    </a>",
"    ). Apoptotic keratinocytes may also be present in the follicular epithelium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/4,10\">",
"     4,10",
"    </a>",
"    ] &nbsp;",
"   </p>",
"   <p>",
"    The lymphocytic infiltrate can be sparse and perivascular or more extensive. Migration of lymphocytes into the epidermis (lymphocyte exocytosis) is common. The presence of satellite cell necrosis (two or more lymphocytes surrounding an apoptotic keratinocyte) also supports a diagnosis of acute GVHD. Fulminant lesions demonstrate subepidermal clefting and full-thickness necrosis of the epidermis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/4,10\">",
"     4,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The criteria often used for categorizing the histopathological findings in acute GVHD are as follows [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Grade 0 &ndash;",
"      </strong>",
"      normal skin or changes not referable to GVHD",
"     </li>",
"     <li>",
"      <strong>",
"       Grade 1 &ndash;",
"      </strong>",
"      vacuolization of the basal layer at the dermal-epidermal junction",
"     </li>",
"     <li>",
"      <strong>",
"       Grade 2 &ndash;",
"      </strong>",
"      Basal layer vacuolization, necrotic epidermal cells, lymphocytic infiltrate (",
"      <a class=\"graphic graphic_picture graphicRef61055 \" href=\"mobipreview.htm?37/37/38487\">",
"       picture 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      <strong>",
"       Grade 3 &ndash;",
"      </strong>",
"      Grade 2 changes plus cleft formation at the dermal-epidermal junction",
"     </li>",
"     <li>",
"      <strong>",
"       Grade 4 &ndash;",
"      </strong>",
"      Grade 2 changes plus separation of the epidermis from the dermis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The sensitivity and specificity of skin biopsy for acute GVHD has not been definitively established. In general, a diagnosis of acute cutaneous GVHD is supported by the appearance of a consistent cutaneous eruption occurring in a time period that correlates with the return of lymphocytes to the peripheral circulation (lymphocyte recovery) and at least grade 2 changes on histopathological examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/12\">",
"     12",
"    </a>",
"    ]. Biopsies taken early in the course of GVHD may reveal nondiagnostic findings. In one retrospective study of 40 biopsy specimens from 38 patients with skin eruptions taken between 3 and 21 days after HCT, the histopathologic findings were nonspecific in all cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, it is unclear whether skin biopsies influence the decision to treat or affect disease outcomes in patients with acute GVHD. Thus, the value of performing a skin biopsy, particularly early in the course of acute GVHD, has been questioned by some authors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. Few studies have investigated the role of skin biopsies. The following studies found little evidence in support of this procedure:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective study of 187 patients who had received allogenic HCT within the preceding 30 days found that the results of skin biopsies (performed in 51 patients who developed skin eruptions suggestive of GVHD) did not influence the likelihood of patients to receive treatment. In addition, skin biopsy results failed to correlate with clinical severity of skin disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a retrospective study of patients who were status post allogenic HCT, 98 skin biopsies from 71 patients with clinical grade 2 or higher acute GVHD were compared to 81 biopsies from 66 patients who did not progress to clinically significant acute GVHD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/17\">",
"       17",
"      </a>",
"      ]. No single histopathologic finding was found to be a statistically significant diagnostic indicator of GVHD. The authors concluded that biopsies were of limited use for determining which patients will progress to grade 2 or higher GVHD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the lack of strong evidence to support performing a skin biopsy in patients with suspected GVHD, a biopsy may provide information that can be used in conjunction with other clinical findings to support a diagnosis of acute GVHD or to establish an alternative cause of the skin eruption. Due to the relative safety of skin biopsy procedures and the known risks associated with immunosuppressive therapy used in the management of acute GVHD, many clinicians, including ourselves, continue to perform skin biopsies in post-HCT patients with skin eruptions for which the differential diagnosis includes acute GVHD. Additional studies are necessary to investigate the utility of skin biopsy in the management of acute GVHD and the most appropriate setting and timing for skin biopsy. Potential adverse effects of skin biopsy include minor bleeding, infection, and scarring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H733005\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple other disorders may present with clinical or histopathologic features that resemble acute GVHD. The following conditions should be considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Drug eruptions &ndash;",
"      </strong>",
"      Differentiation of acute GVHD from a drug eruption may not be possible (",
"      <a class=\"graphic graphic_picture graphicRef54205 \" href=\"mobipreview.htm?37/6/37985\">",
"       picture 5",
"      </a>",
"      ). Morbilliform drug reactions typically develop 7 to 10 days after first exposure to the inciting medication; however, more rapid onset (within one to two days) may occur upon reexposure to an offending agent. Unlike GVHD, which most commonly starts on the head, neck, and acral sites, morbilliform drug reactions typically begin on the torso and spread over several days to involve the lower extremities [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/18,19\">",
"       18,19",
"      </a>",
"      ]. Although the presence of eosinophils on biopsy is often associated with drug eruptions, the presence of eosinophils does not rule out GVHD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=see_link&amp;anchor=H2#H2\">",
"       \"Drug eruptions\", section on 'Classic drug reaction patterns'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Antibiotics, particularly sulfonamides and beta-lactams, are the most common causes of drug eruptions in the post-HCT setting [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/8\">",
"       8",
"      </a>",
"      ]. Phototoxic drug eruptions secondary to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/38/17002?source=see_link\">",
"       voriconazole",
"      </a>",
"      may also be mistaken for GVHD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Viral exanthems &ndash;",
"      </strong>",
"      Viral infections (eg, HHV-6, HHV-7, cytomegalovirus, others) can induce maculopapular or morbilliform eruptions in post-HCT patients (",
"      <a class=\"graphic graphic_picture graphicRef58169 \" href=\"mobipreview.htm?30/60/31685\">",
"       picture 6",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/2,8,22\">",
"       2,8,22",
"      </a>",
"      ]. Skin biopsy specimens secondary to viral exanthems often demonstrate sparse perivascular lymphocytic infiltrates. Disease-specific clinical, laboratory, or histopathological findings (eg, intranuclear inclusions in cytomegalovirus infection), when present, may be useful for distinguishing viral diseases from GVHD.",
"      <br/>",
"      <br/>",
"      The frequency with which viral eruptions cause skin eruptions in post-HCT patients is unclear. A possible relationship between HHV-6 reactivation and the development of GVHD has been proposed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Eruption of lymphocyte recovery &ndash;",
"      </strong>",
"      Lymphocyte recovery describes the return of lymphocytes to the peripheral circulation following marrow ablative therapy. The eruption of lymphocyte recovery is a self-limited skin exanthem associated with transient fever that was first described following recovery of lymphocyte counts in patients treated with chemotherapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/24\">",
"       24",
"      </a>",
"      ]. Unlike GVHD, gastrointestinal and hepatic abnormalities do not occur. Histopathological examination typically demonstrates a superficial perivascular mononuclear cell infiltrate [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/24\">",
"       24",
"      </a>",
"      ]; however, histopathological findings resembling those of grade 1 or 2 acute GVHR also have been observed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Acral erythema &ndash;",
"      </strong>",
"      Acral erythema (also known as palmoplantar erythrodysesthesia) is a complication of chemotherapy (",
"      <a class=\"graphic graphic_picture graphicRef77501 graphicRef79857 \" href=\"mobipreview.htm?20/25/20888\">",
"       picture 7A-B",
"      </a>",
"      ).",
"      <strong>",
"      </strong>",
"      Like acute GVHD, acral erythema affects the palms and soles. Painful symmetrical edema and erythema occur; blistering and desquamation also may develop. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/7/36986?source=see_link&amp;anchor=H23#H23\">",
"       \"Cutaneous complications of conventional chemotherapy agents\", section on 'Acral erythema (hand-foot skin reaction)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Toxic epidermal necrolysis &ndash;",
"      </strong>",
"      Severe cases of acute GVHD share clinical and histopathologic features with toxic epidermal necrolysis, a severe skin reaction typically induced by medication (",
"      <a class=\"graphic graphic_picture graphicRef59418 graphicRef68458 graphicRef82150 graphicRef66134 \" href=\"mobipreview.htm?33/24/34186\">",
"       picture 8A-D",
"      </a>",
"      ). Toxic epidermal necrolysis typically begins with dusky erythematous macules that rapidly progress to extensive blistering and desquamation. Histopathologic examination of established lesions reveals subepidermal bullae and full-thickness epidermal necrosis. Differentiation between severe GVHD and toxic epidermal necrolysis is sometimes impossible. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link\">",
"       \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Engraftment syndrome &ndash;",
"      </strong>",
"      Engraftment syndrome presents with a cutaneous eruption that mimics acute GVHD, fever without identifiable infectious source, and signs of capillary leak syndrome (eg, non-cardiogenic pulmonary edema with hypoxia, weight gain) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/26\">",
"       26",
"      </a>",
"      ]. Engraftment syndrome is most commonly considered a phenomenon of autologous HCT; however, it may also occur after allogenic HCT [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Radiation dermatitis &ndash;",
"      </strong>",
"      Acute radiation dermatitis presents with cutaneous erythema, desquamation, blistering, or cutaneous necrosis. The histopathologic features are similar to acute GVHD, demonstrating vacuolization of the basal layer, apoptotic keratinocytes, satellite cell necrosis, and a superficial perivascular lymphocytic infiltrate.",
"     </li>",
"     <li>",
"      <strong>",
"       Erythema multiforme &ndash;",
"      </strong>",
"      Erythema multiforme is an immune-mediated disorder that most commonly occurs in the setting of herpes simplex virus infection (",
"      <a class=\"graphic graphic_picture graphicRef62370 graphicRef57894 graphicRef51037 \" href=\"mobipreview.htm?42/48/43785\">",
"       picture 9A-C",
"      </a>",
"      ). Like acute GVHD, the histopathologic findings in erythema multiforme include necrotic keratinocytes, subepidermal clefts, and vacuolization of basal keratinocytes. The clinical identification of target and targetoid lesions, suggests a diagnosis of erythema multiforme. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/50/37672?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of erythema multiforme\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18902850\">",
"    <span class=\"h1\">",
"     CHRONIC CUTANEOUS GVHD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic GVHD is a major cause of morbidity and mortality in long-term survivors of allogeneic hematopoietic cell transplantation (HCT). The skin is the most common site of involvement; however, nearly all organ systems may be affected (",
"    <a class=\"graphic graphic_table graphicRef63007 \" href=\"mobipreview.htm?21/15/21757\">",
"     table 2",
"    </a>",
"    ). Chronic GVHD may occur with or without a history of acute GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2692996\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H733638\">",
"    <span class=\"h3\">",
"     Skin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traditionally, chronic cutaneous GVHD has been classified as lichen planus-like or sclerotic (resembling scleroderma); however, many different clinical presentations of chronic GVHD are now recognized, reflecting a spectrum of epidermal and dermal (sclerotic) changes.",
"   </p>",
"   <p>",
"    Cutaneous and extracutaneous diagnostic criteria for chronic GVHD composed by a panel of experts in the National Institutes of Health Consensus project have been published [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/1\">",
"     1",
"    </a>",
"    ]. The panel designated lichen planus-like lesions, sclerotic skin manifestations, and poikilodermatous changes in the skin as clinical features that are diagnostic of chronic GVHD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H877759\">",
"    <span class=\"h4\">",
"     Lichen planus-like lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lichen planus-like chronic GVHD presents as erythematous to violaceous papules or plaques with a predilection for the dorsal hands and feet, forearms, and trunk (",
"    <a class=\"graphic graphic_picture graphicRef55336 \" href=\"mobipreview.htm?34/2/34851\">",
"     picture 10",
"    </a>",
"    ). Fine scale may be present. Lesions closely resemble true lichen planus. Patients may complain of pruritus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=see_link\">",
"     \"Lichen planus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lichen planus-like chronic GVHD also can occur in a follicular distribution, mimicking the appearance of keratosis pilaris (",
"    <a class=\"graphic graphic_picture graphicRef60786 graphicRef68488 \" href=\"mobipreview.htm?33/22/34152\">",
"     picture 11A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/1\">",
"     1",
"    </a>",
"    ]. Lesions in sites of herpes zoster scars, or following Blaschko&rsquo;s lines have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/28\">",
"     28",
"    </a>",
"    ]. Although lichen planus-like GVHD is sometimes considered an earlier form of GVHD than sclerotic GVHD, it is not a prerequisite for the development of sclerotic disease manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/29\">",
"     29",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H877766\">",
"    <span class=\"h4\">",
"     Sclerotic manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sclerotic skin manifestations of chronic GVHD can develop in sites of resolving lichen planus-like lesions or in areas of previously normal skin. Lesions may occur in any location. The depth at which cutaneous sclerosis occurs determines the clinical presentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Morpheaform &ndash;",
"      </strong>",
"      Morphea-like chronic GVHD results from sclerosis that primarily involves the dermis. This variant usually presents with firm, hyperpigmented, hypopigmented, or skin-colored plaques (",
"      <a class=\"graphic graphic_picture graphicRef52693 \" href=\"mobipreview.htm?3/63/4082\">",
"       picture 12",
"      </a>",
"      ). Affected skin often has a shiny appearance and demonstrates hair loss secondary to elimination of adnexal structures. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/8/133?source=see_link\">",
"       \"Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/1/40985?source=see_link\">",
"       \"Localized scleroderma in childhood\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Unlike systemic sclerosis, body surface area involvement in sclerotic GVHD often is discontinuous. In some cases, lesions may preferentially appear in sites of skin trauma (Koebner phenomenon) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. In one series of 58 patients with sclerotic chronic GVHD, 11 (19 percent) exhibited strikingly linear lesions in the waistband area [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/31\">",
"       31",
"      </a>",
"      ]. Extensive involvement of the chest wall may lead to respiratory symptoms secondary to restricted chest expansion.",
"     </li>",
"     <li>",
"      <strong>",
"       Lichen sclerosus-like &ndash;",
"      </strong>",
"      When sclerosis occurs in the superficial dermis, lesions resemble lichen sclerosus, a dermatosis characterized by epidermal atrophy and superficial dermal fibrosis (",
"      <a class=\"graphic graphic_picture graphicRef74154 \" href=\"mobipreview.htm?26/37/27216\">",
"       picture 13A",
"      </a>",
"      ). Lichen sclerosus-like lesions are typically found on the upper back as white or gray thin plaques with accentuated dermatoglyphics.",
"     </li>",
"     <li>",
"      <strong>",
"       Deep",
"       <span class=\"nowrap\">",
"        sclerosis/eosinophilic",
"       </span>",
"       fasciitis-like &ndash;",
"      </strong>",
"      Deep sclerosis may also occur. Subcutaneous fibrosis results in a cellulite-like rippled appearance to the skin due to thickening of the fibrous septae within fat, particularly on the medial arms and thighs (",
"      <a class=\"graphic graphic_picture graphicRef64464 \" href=\"mobipreview.htm?18/44/19151\">",
"       picture 14",
"      </a>",
"      ). Fascial involvement tends to occur late in the chronic period, and may lead to the appearance of prominent linear demarcations, often referred to as the &ldquo;groove sign,&rdquo; and contractures that limit range of motion (",
"      <a class=\"graphic graphic_picture graphicRef76298 \" href=\"mobipreview.htm?4/2/4130\">",
"       picture 15",
"      </a>",
"      ). In eosinophilic-fasciitis-like cases, these findings of deep sclerosis are often accompanied by pain and edema [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/30\">",
"       30",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/10/8360?source=see_link\">",
"       \"Eosinophilic fasciitis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The development of bullae or ulcerations may complicate sclerotic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/24/18826?source=see_link\">",
"     \"Pathogenesis of graft-versus-host disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H450616\">",
"    <span class=\"h4\">",
"     Poikiloderma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Poikiloderma describes the combination of atrophy, hypopigmentation, and hyperpigmentation in the skin. Poikilodermatous skin changes in chronic GVHD appear as patches with mottled pigmentation and telangiectasias (",
"    <a class=\"graphic graphic_picture graphicRef66942 \" href=\"mobipreview.htm?5/46/5858\">",
"     picture 16",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H877975\">",
"    <span class=\"h4\">",
"     Other cutaneous findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to poikiloderma, other pigment disorders may occur in chronic GVHD, including the appearance of depigmented, hypopigmented, and hyperpigmented areas. Hyperpigmentation may occur in a widespread, leopard-skin like pattern. In one series of 17 patients with sclerotic chronic GVHD, 10 (59 percent) had a history of the appearance of multiple hyperpigmented macules with fine scale prior to the development of sclerotic lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Widespread eczematous lesions and malar eruptions resembling systemic lupus erythematosus have been reported as histopathologically confirmed manifestations of chronic GVHD in small series of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Other cutaneous findings associated with chronic GVHD include hypohidrosis, ichthyosis, erythema, pruritus, and maculopapular eruptions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H733440\">",
"    <span class=\"h3\">",
"     Oral lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Forty-five to 83 percent of patients with chronic GVHD develop oral involvement (",
"    <a class=\"graphic graphic_picture graphicRef73344 graphicRef82463 graphicRef61588 \" href=\"mobipreview.htm?6/22/6506\">",
"     picture 17A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/7\">",
"     7",
"    </a>",
"    ]. Lacy or reticulated white plaques that resemble Wickham&rsquo;s striae of lichen planus may occur on the tongue, buccal mucosa, lips, or palate. Hyperkeratotic plaques, mucosal erythema, erosions, and ulceration can also occur. Associated pain may inhibit oral intake [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/35\">",
"     35",
"    </a>",
"    ]. In patients with sclerotic GVHD, perioral sclerosis can lead to restricted oral aperture, further complicating dental hygiene and nutritional status.",
"   </p>",
"   <p>",
"    In addition, patients may suffer from sicca symptoms resembling those that occur in Sj&ouml;gren's syndrome secondary to impairment of salivary gland function. Mucoceles, which are fluid-filled smooth nodules on the oral mucosa that represent accumulations of sialomucin from minor salivary glands in the oral mucosa, may also occur (",
"    <a class=\"graphic graphic_picture graphicRef70332 \" href=\"mobipreview.htm?38/2/38944\">",
"     picture 18",
"    </a>",
"    ). Mucoceles result from obstruction of the salivary duct, and are thought to be related to salivary gland inflammation associated with chronic GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The NIH Consensus Development Project classified oral lichen-planus-like changes, hyperkeratotic plaques, and restriction of mouth opening due to sclerosis as diagnostic features of oral chronic GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Oral verruciform xanthoma (mucosal plaques characterized histologically by epithelial hyperplasia and foamy macrophages) is a rare finding that has been documented in a few patients with chronic GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/36\">",
"     36",
"    </a>",
"    ]. Oral verruciform xanthomas may also occur on normal mucosa, or in the setting of oral lichen planus or other inflammatory diseases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H733454\">",
"    <span class=\"h3\">",
"     Hair disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scarring or nonscarring alopecia or scaly papules on the scalp may occur in chronic GVHD, but are not sufficient to establish the diagnosis in the absence of other findings consistent with GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/1\">",
"     1",
"    </a>",
"    ]. Thinning hair, patchy hair loss, coarse or dull hair, and premature graying have also been associated with this disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H733461\">",
"    <span class=\"h3\">",
"     Nail disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of nail abnormalities ranging from mild nail dystrophy to total nail loss (anonychia) may occur (",
"    <a class=\"graphic graphic_picture graphicRef71229 \" href=\"mobipreview.htm?28/42/29345\">",
"     picture 19",
"    </a>",
"    ). Examples of associated nail abnormalities include longitudinal ridging, splitting or brittle nails, onycholysis (separation of the nail plate from the nail bed), and pterygium (abnormal adherence of the nail plate to the proximal nail fold or hyponychium).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H733468\">",
"    <span class=\"h3\">",
"     Ocular and genital mucosa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammation of the conjunctiva, pseudomembranous or cicatricial conjunctivitis, and keratoconjunctivitis sicca (dry eye) syndrome may occur in patients with chronic GVHD. Symptoms of ocular irritation, pain, or visual changes may accompany these findings. Vulvar or vaginal erosions, lichen planus-like lesions, or sclerosis leading to labial resorption or tissue agglutination also may occur in affected women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3566637\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue biopsies are recommended to confirm chronic GVHD in the absence of diagnostic clinical findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/1,37\">",
"     1,37",
"    </a>",
"    ]. A summary of the common and diagnostic clinical features of chronic GVHD, as defined by the National Institutes of Health Consensus Project, is provided in a table (",
"    <a class=\"graphic graphic_table graphicRef63007 \" href=\"mobipreview.htm?21/15/21757\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The histopathological changes in chronic GVHD vary according to the type of skin involvement. The classic findings in lichen planus-like and sclerotic lesions are discussed below: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Lichen planus-like lesions &ndash;",
"      </strong>",
"      Lichen-planus like papules and plaques reveal findings that resemble lichen planus, with hyperkeratosis, hypergranulosis, acanthosis, saw-tooth rete, interface dermatitis, and dyskeratotic keratinocytes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/37\">",
"       37",
"      </a>",
"      ]. Periadnexal inflammation, particularly around eccrine glands is evident in some cases.",
"     </li>",
"     <li>",
"      <strong>",
"       Sclerotic lesions &ndash;",
"      </strong>",
"      Sclerotic skin involvement may or may not demonstrate overlying epidermal changes of lichen planus-like disease. Lichen sclerosus-like lesions characteristically show epidermal atrophy with edema and homogenization of collagen in the superficial dermis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/2\">",
"       2",
"      </a>",
"      ]. Morpheaform lesions demonstrate thickened collagen bundles in the dermis with loss of adnexal structures, and in the absence of epidermal changes, may be indistinguishable from specimens from true morphea or systemic sclerosis. As in these other disorders, specimens from lesions of sclerotic chronic GVHD often have a square or &ldquo;box car&rdquo; shape to the biopsy. Sclerotic GVHD involving the subcutaneous tissue demonstrates a lymphocytic infiltrate near the interface of dermis and fat with thickening of the septae.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A 4 mm punch biopsy is sufficient for the evaluation of lichen planus-like, lichen sclerosus-like, and most morpheaform lesions. Deep incisional biopsy is often necessary to evaluate for fascial involvement. Magnetic resonance imaging (MRI) also may have value for the diagnosis of subcutaneous disease and fasciitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. The efficacy of MRI for long-term monitoring of disease activity is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H733020\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several disorders share clinical and histopathologic features with chronic GVHD.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Lichen planus-like lesions &ndash;",
"      </strong>",
"      The clinical and histopathologic features of lichen planus-like GVHD closely resemble lichen planus. Lesions of GVHD may be less angular and may have less well-defined margins than lichen planus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/4\">",
"       4",
"      </a>",
"      ]. The flexural wrists and shins are classic sites for true lichen planus (",
"      <a class=\"graphic graphic_picture graphicRef76383 graphicRef63590 \" href=\"mobipreview.htm?33/58/34727\">",
"       picture 20A-B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=see_link\">",
"       \"Lichen planus\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Lichenoid drug eruptions and pityriasis lichenoides chronica are additional disorders that may present with widespread erythematous papules and interface dermatitis (",
"      <a class=\"graphic graphic_picture graphicRef80165 graphicRef59258 graphicRef71210 \" href=\"mobipreview.htm?24/52/25418\">",
"       picture 21A-C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Sclerotic lesions &ndash;",
"      </strong>",
"      Sclerotic lesions can mimic lichen sclerosus, morphea, systemic sclerosis, and eosinophilic fasciitis (",
"      <a class=\"graphic graphic_picture graphicRef74154 graphicRef56113 graphicRef82198 graphicRef50218 \" href=\"mobipreview.htm?11/35/11834\">",
"       picture 13A-D",
"      </a>",
"      ). Of note, the distal to proximal progression of cutaneous sclerosis on the extremities that is characteristic of systemic sclerosis typically is not observed in chronic GVHD. Radiation-induced fibrosis and nephrogenic fibrosing dermopathy can also present with induration and thickening of the skin. The possibility of nephrogenic fibrosing dermopathy should be considered in patients with renal failure. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/8/133?source=see_link\">",
"       \"Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/1/40985?source=see_link\">",
"       \"Localized scleroderma in childhood\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/10/8360?source=see_link\">",
"       \"Eosinophilic fasciitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/22/31082?source=see_link\">",
"       \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Poikiloderma &ndash;",
"      </strong>",
"      Poikiloderma can occur in a variety of disorders, most commonly on the lateral necks of fair-skinned individuals as poikiloderma of Civatte, a condition that is thought to be related to chronic sun exposure (",
"      <a class=\"graphic graphic_picture graphicRef81779 \" href=\"mobipreview.htm?32/52/33602\">",
"       picture 22",
"      </a>",
"      ). Additional disorders that may present with poikiloderma include dermatomyositis, systemic lupus erythematosus, Rothmund-Thompson syndrome, Bloom syndrome, and poikiloderma vasculare atrophicans in the setting of parapsoriasis or cutaneous T-cell lymphoma (",
"      <a class=\"graphic graphic_picture graphicRef63888 \" href=\"mobipreview.htm?39/16/40196\">",
"       picture 23",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3496567\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3886460\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic therapy is generally required for the management of patients with acute GVHD. High potency topical corticosteroids may provide improvement in patients with limited skin disease and no internal involvement. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10425?source=see_link\">",
"     \"Prevention and treatment of acute graft-versus-host disease: Recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Phototherapy may be an additional treatment option for acute cutaneous GVHD. In retrospective studies, psoralen plus UVA (PUVA) and narrow band UVB phototherapy have been associated with improvement in acute cutaneous GVHD that was refractory to systemic glucocorticoid therapy or that flared upon glucocorticoid tapering [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Prior to a recommendation for the routine use of phototherapy, further study is necessary to determine the long-term safety and efficacy of phototherapy in this population.",
"   </p>",
"   <p>",
"    Topical corticosteroids and topical calcineurin inhibitors may have some benefit for patients with limited non-sclerotic chronic GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/42\">",
"     42",
"    </a>",
"    ]. Phototherapy and systemic therapies are the mainstays of treatment for patients with sclerotic lesions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35385?source=see_link\">",
"     \"Treatment of chronic graft-versus-host disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H878120\">",
"    <span class=\"h2\">",
"     Ancillary measures in chronic GVHD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chronic cutaneous GVHD benefit from preventive skin care recommendations, including skin cancer surveillance, monitoring for adverse effects of topical corticosteroids, management of pruritus, and wound care and infection control measures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Guidelines for ancillary therapy and supportive care of chronic GVHD were proposed by the NIH Consensus Development Project [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/43\">",
"     43",
"    </a>",
"    ]. Recommendations included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Photoprotection",
"     </li>",
"     <li>",
"      Regular use of emollients on intact skin",
"     </li>",
"     <li>",
"      Careful use of topical corticosteroids to reduce risk for cutaneous atrophy",
"     </li>",
"     <li>",
"      Use of topical or systemic antipruritic agents when needed",
"     </li>",
"     <li>",
"      Wound management",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Cutaneous squamous cell carcinoma (SCC) is a potential long term complication of HCT; the development of multiple cutaneous SCCs has been reported in patients chronic GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. Immunosuppression, psoralen plus UVA (PUVA) phototherapy, and chronic wounds are associated with elevated risk for cutaneous SCC, and may contribute to the development of SCC in this population. Patients should be encouraged to engage in sun protective practices, including the use of broad spectrum sunscreens, sun protective clothing, and sun avoidance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/43\">",
"     43",
"    </a>",
"    ]. In addition, patients should be examined periodically for signs of skin cancer. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/39/28280?source=see_link&amp;anchor=H1273804#H1273804\">",
"     \"Malignancy after hematopoietic cell transplantation\", section on 'Squamous cell cancers'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Daily use of emollients may reduce pruritus, and may be beneficial for maintaining skin integrity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/43\">",
"     43",
"    </a>",
"    ]. Ointment or creams, rather than less-occlusive lotion formulations are preferred. Topical anti-pruritic agents such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/49/32528?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/5/17491?source=see_link\">",
"     pramoxine",
"    </a>",
"    or menthol-containing lotions or creams may also be beneficial for pruritus. In patients with significant symptoms, oral antipruritics such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/24/391?source=see_link\">",
"     hydroxyzine",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/51/32560?source=see_link\">",
"     doxepin",
"    </a>",
"    may be used.",
"   </p>",
"   <p>",
"    When topical corticosteroids, particularly high potency agents, are used, patients should be monitored for signs of cutaneous atrophy. Utilizing lower potency agents (class VI-VII) on areas at high risk for atrophy (face and intertriginous areas) may reduce this risk (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"mobipreview.htm?38/56/39809\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27752?source=see_link&amp;anchor=H16#H16\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Spontaneous ulceration can occur in patients with sclerotic chronic GVHD. Areas of skin breakdown should be assessed for the possibility of infection or malignancy and cultured, biopsied, and treated as appropriate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/43\">",
"     43",
"    </a>",
"    ]. Chronic wounds in the setting of GVHD may be challenging to heal, and referral to a wound care center may be beneficial. Plastic surgery consultation is useful in some cases.",
"   </p>",
"   <p>",
"    Patients should be educated regarding early signs of skin sclerosis, such as skin tightness, edema, and reduced range of motion, and should be instructed to seek care if these symptoms occur. Serial clinical photography and range of motion assessment are useful for documenting changes in skin activity over time in patients with sclerotic chronic GVHD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H451212\">",
"    <span class=\"h2\">",
"     Oral lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical high potency corticosteroids are often used for the treatment of oral GVHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/7\">",
"     7",
"    </a>",
"    ]. Supportive interventions for patients with oral chronic GVHD include encouraging good oral hygiene and utilizing of topical anesthetic agents, such as viscous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    , to reduce pain and facilitate oral intake.",
"   </p>",
"   <p>",
"    There are multiple reports of oral SCC in patients with chronic GVHD, and patients should be followed closely for the development of oral malignancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/47\">",
"     47",
"    </a>",
"    ]. Leukoplakia may be a benign manifestation of chronic GVHD or a precursor to oral SCC. Leukoplakia that fails to improve or worsens despite therapy should be biopsied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with xerostomia may benefit from salivary stimulants (sugarless gum or candy), oral lubricants or saliva substitutes, and topical fluoride to prevent tooth decay. Cholinergic agonists to stimulate saliva production (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/36/33344?source=see_link\">",
"     pilocarpine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/40/12932?source=see_link\">",
"     cevimeline",
"    </a>",
"    ) may be useful in patients in whom the use of these agents is not contraindicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/57/36762?source=see_link\">",
"     \"Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No therapy is necessary for small, superficial mucoceles [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/5/42073/abstract/43\">",
"     43",
"    </a>",
"    ]. Deep lesions that cause discomfort can be surgically excised.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H451219\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Graft-versus-host-disease (GVHD) is a common complication of hematopoietic cell transplant (HCT) that results from recognition of host antigens by immunocompetent cells from the donor. Cutaneous manifestations commonly occur in both acute and chronic GVHD. (See",
"      <a class=\"local\" href=\"#H3496485\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2692898\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute GVHD usually begins with erythematous macules on the ears, palms, soles, neck, face, or upper back. Lesions subsequently become more generalized; severe cases exhibit erythroderma, bullae, and extensive epidermal necrosis. Little is known about oral involvement in acute GVHD. (See",
"      <a class=\"local\" href=\"#H18902811\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Characteristic histopathologic findings in acute GVHD include vacuolization of the basal layer of the epidermis, a sparse lymphocytic dermal infiltrate, and apoptotic keratinocytes. Advanced lesions demonstrate subepidermal clefts and extensive epidermal necrosis. (See",
"      <a class=\"local\" href=\"#H18902827\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The value of skin biopsy in acute GVHD has been questioned. Biopsies can yield nonspecific results. In all cases, histopathological findings require clinical correlation for proper interpretation. (See",
"      <a class=\"local\" href=\"#H18902827\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A variety of disorders, including drug eruptions, viral exanthems, and toxic epidermolytic necrosis share clinical",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      histopathological features with acute cutaneous GVHD. The possibility of other disorders must be considered in hematopoietic stem cell transplant patients who present with clinical or histopathological findings suggestive of acute cutaneous GVHD. (See",
"      <a class=\"local\" href=\"#H733005\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic GVHD presents in a number of different morphologies involving the epidermis, dermis, or subcutaneous tissues. Lichen planus-like lesions resemble the dermatologic disease lichen planus, whereas sclerotic involvement may resemble morphea, lichen sclerosus, or eosinophilic fasciitis. Dyspigmentation and other cutaneous, hair, or nail abnormalities have been associated with chronic GVHD. Oral involvement is common. (See",
"      <a class=\"local\" href=\"#H2692996\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with chronic GVHD may benefit from the use of emollients and topical or systemic antipruritic agents. Patients should also be followed closely for the development of cutaneous or oral squamous cell carcinoma. Agents to reduce oral pain or xerostomia are useful. (See",
"      <a class=\"local\" href=\"#H3496567\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/1\">",
"      Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/2\">",
"      Pe&ntilde;as PF, Zaman S. Many faces of graft-versus-host disease. Australas J Dermatol 2010; 51:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/3\">",
"      Goddard DS, Horn BN, McCalmont TH, Cordoro KM. Clinical update on graft-versus-host disease in children. Semin Cutan Med Surg 2010; 29:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/4\">",
"      Vargas-D&iacute;ez E, Garc&iacute;a-D&iacute;ez A, Mar&iacute;n A, Fern&aacute;ndez-Herrera J. Life-threatening graft-vs-host disease. Clin Dermatol 2005; 23:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/5\">",
"      Friedman KJ, LeBoit PE, Farmer ER. Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation. Arch Dermatol 1988; 124:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/6\">",
"      Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/7\">",
"      Imanguli MM, Alevizos I, Brown R, et al. Oral graft-versus-host disease. Oral Dis 2008; 14:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/8\">",
"      Mays SR, Kunishige JH, Truong E, et al. Approach to the morbilliform eruption in the hematopoietic transplant patient. Semin Cutan Med Surg 2007; 26:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/9\">",
"      Tsoi MS, Storb R, Jones E, et al. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. J Immunol 1978; 120:1485.",
"     </a>",
"    </li>",
"    <li>",
"     Weedon D. The lichenoid reaction pattern (interface dermatitis). In: Weedon's Skin Pathology, 3rd, Elsevier Limited, China 2010. p.35.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/11\">",
"      Lerner KG, Kao GF, Storb R, et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974; 6:367.",
"     </a>",
"    </li>",
"    <li>",
"     Sharp MT, Horn TD. Graft-versus-host disease. In: Fitzpatrick's Dermatology in General Medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI, et al. (Eds), McGraw-Hill, 2008. p.258.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/13\">",
"      Kuykendall TD, Smoller BR. Lack of specificity in skin biopsy specimens to assess for acute graft-versus-host disease in initial 3 weeks after bone-marrow transplantation. J Am Acad Dermatol 2003; 49:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/14\">",
"      Zhou Y, Barnett MJ, Rivers JK. Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation. Arch Dermatol 2000; 136:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/15\">",
"      Firoz BF, Lee SJ, Nghiem P, Qureshi AA. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. Arch Dermatol 2006; 142:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/16\">",
"      Drijkoningen M, De Wolf-Peeters C, Tricot G, et al. Drug-induced skin reactions and acute cutaneous graft-versus-host reaction: a comparative immunohistochemical study. Blut 1988; 56:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/17\">",
"      Kohler S, Hendrickson MR, Chao NJ, Smoller BR. Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. Am J Surg Pathol 1997; 21:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/18\">",
"      Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001; 53:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/19\">",
"      Byun HJ, Yang JI, Kim BK, Cho KH. Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions. J Am Acad Dermatol 2011; 65:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/20\">",
"      Marra DE, McKee PH, Nghiem P. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J Am Acad Dermatol 2004; 51:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/21\">",
"      Patel AR, Turner ML, Baird K, et al. Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2009; 15:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/22\">",
"      Yoshikawa T, Ihira M, Ohashi M, et al. Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/23\">",
"      Kitamura K, Asada H, Iida H, et al. Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation. J Am Acad Dermatol 2008; 58:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/24\">",
"      Horn TD, Redd JV, Karp JE, et al. Cutaneous eruptions of lymphocyte recovery. Arch Dermatol 1989; 125:1512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/25\">",
"      Bauer DJ, Hood AF, Horn TD. Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery. Arch Dermatol 1993; 129:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/26\">",
"      Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/27\">",
"      Carreras E, Fern&aacute;ndez-Avil&eacute;s F, Silva L, et al. Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center. Bone Marrow Transplant 2010; 45:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/28\">",
"      Schaffer JV. The changing face of graft-versus-host disease. Semin Cutan Med Surg 2006; 25:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/29\">",
"      Pe&ntilde;as PF, Jones-Caballero M, Arag&uuml;&eacute;s M, et al. Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients. Arch Dermatol 2002; 138:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/30\">",
"      Schaffer JV, McNiff JM, Seropian S, et al. Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. J Am Acad Dermatol 2005; 53:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/31\">",
"      Patel AR, Pavletic SZ, Turner ML, Cowen EW. The isomorphic response in morphealike chronic graft-vs-host disease. Arch Dermatol 2008; 144:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/32\">",
"      Martires KJ, Baird K, Citrin DE, et al. Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses. Arch Dermatol 2011; 147:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/33\">",
"      Creamer D, Martyn-Simmons CL, Osborne G, et al. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy. Arch Dermatol 2007; 143:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/34\">",
"      Goiriz R, Pe&ntilde;as PF, Delgado-Jim&eacute;nez Y, et al. Cutaneous lichenoid graft-versus-host disease mimicking lupus erythematosus. Lupus 2008; 17:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/35\">",
"      Imanguli MM, Pavletic SZ, Guadagnini JP, et al. Chronic graft versus host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/36\">",
"      Shahrabi Farahani S, Treister NS, Khan Z, Woo SB. Oral verruciform xanthoma associated with chronic graft-versus-host disease: a report of five cases and a review of the literature. Head Neck Pathol 2011; 5:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/37\">",
"      Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006; 12:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/38\">",
"      Clark J, Yao L, Pavletic SZ, et al. Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease. Arch Dermatol 2009; 145:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/39\">",
"      Oda K, Nakaseko C, Ozawa S, et al. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transplant 2009; 43:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/40\">",
"      Furlong T, Leisenring W, Storb R, et al. Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/41\">",
"      Feldstein JV, Bola&ntilde;os-Meade J, Anders VL, Abuav R. Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin. J Am Acad Dermatol 2011; 65:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/42\">",
"      Marks C, Stadler M, H&auml;usermann P, et al. German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD. Br J Dermatol 2011; 165:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/43\">",
"      Couriel D, Carpenter PA, Cutler C, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006; 12:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/44\">",
"      Altman JS, Adler SS. Development of multiple cutaneous squamous cell carcinomas during PUVA treatment for chronic graft-versus-host disease. J Am Acad Dermatol 1994; 31:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/45\">",
"      Brown SJ, Jackson GH, Reynolds NJ, Lawrence CM. Chronic cutaneous graft-versus-host disease associated with multiple cutaneous squamous cell carcinomas. Clin Exp Dermatol 2006; 31:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/46\">",
"      Howe NR, Lang PG. Squamous cell carcinoma of the sole in a patient with chronic graft-vs-host disease. Arch Dermatol 1988; 124:1244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/5/42073/abstract/47\">",
"      Demarosi F, Soligo D, Lodi G, et al. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100:63.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13760 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.96.59.103-8AD9A5E0CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42073=[""].join("\n");
var outline_f41_5_42073=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H451219\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3496485\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2692898\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18902803\">",
"      ACUTE CUTANEOUS GVHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18902811\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H878137\">",
"      - Skin lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H733754\">",
"      - Oral lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18902827\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H832193\">",
"      - Skin biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H733005\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18902850\">",
"      CHRONIC CUTANEOUS GVHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2692996\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H733638\">",
"      - Skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H877759\">",
"      Lichen planus-like lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H877766\">",
"      Sclerotic manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H450616\">",
"      Poikiloderma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H877975\">",
"      Other cutaneous findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H733440\">",
"      - Oral lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H733454\">",
"      - Hair disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H733461\">",
"      - Nail disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H733468\">",
"      - Ocular and genital mucosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3566637\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H733020\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3496567\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3886460\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H878120\">",
"      Ancillary measures in chronic GVHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H451212\">",
"      Oral lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H451219\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13760\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13760|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/30/27107\" title=\"picture 1\">",
"      Acute GVHD palm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/7/6258\" title=\"picture 2\">",
"      Acute GVHD follicular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/41/659\" title=\"picture 3\">",
"      Acute GVHD erythroderma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/37/38487\" title=\"picture 4\">",
"      Acute GVHD histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/6/37985\" title=\"picture 5\">",
"      Morbilliform drug eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/60/31685\" title=\"picture 6\">",
"      Viral exanthem",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?21/58/22436\" title=\"picture 7A\">",
"      Acral erythema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/12/11458\" title=\"picture 7B\">",
"      Acral erythema on the hands",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/27/13747\" title=\"picture 8A\">",
"      Toxic epidermal necrolysis - abdomen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/1/39953\" title=\"picture 8B\">",
"      Toxic epidermal necrolysis - back",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/18/35106\" title=\"picture 8C\">",
"      Toxic epidermal necrolysis - bullae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/63/18419\" title=\"picture 8D\">",
"      Toxic epidermal necrolysis I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/14/13540\" title=\"picture 9A\">",
"      Erythema multiforme acral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/55/14193\" title=\"picture 9B\">",
"      Erythema multiforme extrem",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?40/27/41393\" title=\"picture 9C\">",
"      Erythema multiforme atypica",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/2/34851\" title=\"picture 10\">",
"      Lichenoid chronic GVHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/3/26672\" title=\"picture 11A\">",
"      Keratosis pilaris fair skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/26/18854\" title=\"picture 11B\">",
"      Keratosis pilaris dark skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?3/63/4082\" title=\"picture 12\">",
"      Sclerotic chronic GVHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/37/27216\" title=\"picture 13A\">",
"      Lichen sclerosus - trunk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?1/38/1632\" title=\"picture 13B\">",
"      Generalized morphea - trunk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/22/2403\" title=\"picture 13C\">",
"      Pansclerotic morphea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/35/5681\" title=\"picture 13D\">",
"      Eosinophilic fasciitis thigh",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/44/19151\" title=\"picture 14\">",
"      Chronic GVHD - subcutaneous",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/2/4130\" title=\"picture 15\">",
"      Chronic GVHD - range of motion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/46/5858\" title=\"picture 16\">",
"      Chronic GVHD - poikiloderma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/16/11520\" title=\"picture 17A\">",
"      Chronic GVHD buccal mucosa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/33/25106\" title=\"picture 17B\">",
"      Chronic GVHD tongue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/37/28245\" title=\"picture 17C\">",
"      Chronic GVHD tongue erosions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/2/38944\" title=\"picture 18\">",
"      Mucocele - lower lip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?28/42/29345\" title=\"picture 19\">",
"      Chronic GVHD nail dystrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?28/42/29346\" title=\"picture 20A\">",
"      Lichen planus wrists fair skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/29/18898\" title=\"picture 20B\">",
"      Lichen planus flexures dark skin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/5/40021\" title=\"picture 21A\">",
"      Lichenoid drug eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/33/35348\" title=\"picture 21B\">",
"      Lichenoid drug eruption hyperpigmentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?18/50/19233\" title=\"picture 21C\">",
"      Pityriasis lichenoides chronica",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/52/33602\" title=\"picture 22\">",
"      Poikiloderma of Civatte",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/16/40196\" title=\"picture 23\">",
"      Mycosis fungoides poikiloderma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13760|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/63/9212\" title=\"table 1A\">",
"      Grade GVHD by organ system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/15/43260\" title=\"table 1B\">",
"      Overall grading of acute GVHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/15/21757\" title=\"table 2\">",
"      Features of chronic GVHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/56/39809\" title=\"table 3\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/22/25960?source=related_link\">",
"      Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23962?source=related_link\">",
"      Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/7/36986?source=related_link\">",
"      Cutaneous complications of conventional chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=related_link\">",
"      Drug eruptions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/10/8360?source=related_link\">",
"      Eosinophilic fasciitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=related_link\">",
"      Lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/1/40985?source=related_link\">",
"      Localized scleroderma in childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/39/28280?source=related_link\">",
"      Malignancy after hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/22/31082?source=related_link\">",
"      Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/22/38250?source=related_link\">",
"      Oral toxicity associated with chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/24/18826?source=related_link\">",
"      Pathogenesis of graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/50/37672?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of erythema multiforme",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/8/133?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/11/10425?source=related_link\">",
"      Prevention and treatment of acute graft-versus-host disease: Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/35/35385?source=related_link\">",
"      Treatment of chronic graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/57/36762?source=related_link\">",
"      Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_5_42074="ECG Wolff-Parkinson-White syndrome";
var content_f41_5_42074=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63783&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63783&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1184px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Wolff-Parkinson-White pattern",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 295px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Precordial leads in a patient with preexcitation due to the WPW syndrome. The three characteristic findings are the short PR interval (0.09 sec in this case), the wide QRS, and the delta wave (slurring of the QRS upstroke) that is best seen in leads V5 and V6 (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42074=[""].join("\n");
var outline_f41_5_42074=null;
var title_f41_5_42075="Manifestations of insulin resis";
var content_f41_5_42075=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F73294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F73294&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations of insulin resistance",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Glucose homeostasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Variable, including overt diabetes, impaired glucose tolerance, normal, and hypoglycemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cutaneous",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acanthosis nigricans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin tags",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alopecia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Reproductive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amenorrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hirsutism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Virilization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infertility (in women)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Linear growth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Variable, including normal, impaired, increased",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Adipose tissue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Variable, including normal, lipoatrophy, lipohypertrophy, obesity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Musculoskeletal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Variable, including normal, cramps, muscle hypertrophy, pseudoacromegaly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Lipid metabolism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal or hypertriglyceridemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Autoimmunity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Type B syndrome with variety of immune phenotypes",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42075=[""].join("\n");
var outline_f41_5_42075=null;
var title_f41_5_42076="Prevalence of dyspnea in advanced illness";
var content_f41_5_42076=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F60535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F60535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prevalence of dyspnea in select advanced illnesses",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Population",
"       </td>",
"       <td class=\"subtitle1\">",
"        Prevalence of dyspnea (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        References",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cancer (mixed)",
"       </td>",
"       <td>",
"        10 to 70",
"       </td>",
"       <td>",
"        Solano 2006",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AIDS",
"       </td>",
"       <td>",
"        11 to 62",
"       </td>",
"       <td>",
"        Solano 2006",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lung cancer (primary or metastatic)",
"       </td>",
"       <td>",
"        62 to 95",
"       </td>",
"       <td>",
"        Currow 2010",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heart disease",
"       </td>",
"       <td>",
"        60 to 88",
"       </td>",
"       <td>",
"        Solano 2006",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        COPD",
"       </td>",
"       <td>",
"        90 to 95",
"       </td>",
"       <td>",
"        Solano 2006",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal disease",
"       </td>",
"       <td>",
"        11 to 62",
"       </td>",
"       <td>",
"        Solano 2006",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stroke",
"       </td>",
"       <td>",
"        37",
"       </td>",
"       <td>",
"        Addington-Hall 1995",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ALS",
"       </td>",
"       <td>",
"        47 to 50",
"       </td>",
"       <td>",
"        O'Brien 1992",
"        <sup>",
"         [4]",
"        </sup>",
"        , Hicks 1993",
"        <sup>",
"         [5]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dementia",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        Lloyd-Williams 1996",
"        <sup>",
"         [6]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No cardiorespiratory disease (ie, no primary or secondary lung malignancy, cardiac failure, or respiratory disease)",
"       </td>",
"       <td>",
"        45 to 81",
"       </td>",
"       <td>",
"        Currow 2010",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AIDS: acquired immunodeficiency syndrome; COPD: chronic obstructive pulmonary disease; ALS: amyotrophic lateral sclerosis.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006; 31:58.",
"       </li>",
"       <li>",
"        Currow DC, Smith J, Davidson PM, et al. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage 2010; 39:680.",
"       </li>",
"       <li>",
"        Addington-Hall J, Lay M, Altmann D, et al. Symptom control, communication with health professionals, and hospital care of stroke patients in the last year of life as reported by surviving family, friends and officials. Stroke 1995; 26:2242.",
"       </li>",
"       <li>",
"        O'Brien T, Kelly M, Saunders C. Motor neuron disease: a hospice perspective. BMJ 1992; 304:471.",
"       </li>",
"       <li>",
"        Hicks F, Corcoran G. Should hospices offer respite admissions to patient with motor neurone disease? Palliat Med 1993; 7:145.",
"       </li>",
"       <li>",
"        Lloyd-Williams M. A survey of palliative care given to patients with end-stage dementia (abstract). Palliat Med 1996; 10:63.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42076=[""].join("\n");
var outline_f41_5_42076=null;
var title_f41_5_42077="pH and H concentration";
var content_f41_5_42077=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F68879&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F68879&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Relationship between the pH and H+ concentration (in nanomol or nanoeq/L) in the physiologic range",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 203px; height: 164px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42077=[""].join("\n");
var outline_f41_5_42077=null;
var title_f41_5_42078="12-lead ECG epsilon wave and T wave inversions in ARVC";
var content_f41_5_42078=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F60781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F60781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) showing epsilon wave and T wave inversions in arrhythmogenic right ventricular cardiomyopathy (ARVC)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 386px; height: 229px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Twelve lead electrocardiogram in a patient with arrhythmogenic right ventricular cardiomyopathy (ARVC) showing deep T wave inversions in V2 to V4, compatible with right ventricular disease, and epsilon waves just after the QRS complex (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Jaoude S, Leclercq JF, Coumel P. Eur Heart J 1996; 17:1717.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42078=[""].join("\n");
var outline_f41_5_42078=null;
var title_f41_5_42079="Malignant mesothelioma IV MRI";
var content_f41_5_42079=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74112&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74112&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant mesothelioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 321px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    MRI scan, sagittal T2 weighted sequence, shows large right sided pleural effusion layering dorsally in this recumbent patient. The diaphragm is intact. Above the lung apex, the right subclavian vein is seen in cross- section and forms a bright round signal. Behind it is the right subclavian artery forming a smaller circle. Above the vascular structures, the brachial plexus is seen in cross-section forming several less bright rounded structures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_5_42079=[""].join("\n");
var outline_f41_5_42079=null;
